WO2019072247A1 - Ultra-high-performance liquid chromatography detection method for traditional chinese medicine composition - Google Patents

Ultra-high-performance liquid chromatography detection method for traditional chinese medicine composition Download PDF

Info

Publication number
WO2019072247A1
WO2019072247A1 PCT/CN2018/110123 CN2018110123W WO2019072247A1 WO 2019072247 A1 WO2019072247 A1 WO 2019072247A1 CN 2018110123 W CN2018110123 W CN 2018110123W WO 2019072247 A1 WO2019072247 A1 WO 2019072247A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
parts
chinese medicine
traditional chinese
medicine composition
Prior art date
Application number
PCT/CN2018/110123
Other languages
French (fr)
Chinese (zh)
Inventor
王伽伯
肖小河
张海珠
牛明
马永刚
王宏涛
田书彦
Original Assignee
石家庄以岭药业股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 石家庄以岭药业股份有限公司 filed Critical 石家庄以岭药业股份有限公司
Publication of WO2019072247A1 publication Critical patent/WO2019072247A1/en

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N30/14Preparation by elimination of some components
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/34Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N30/14Preparation by elimination of some components
    • G01N2030/146Preparation by elimination of some components using membranes

Definitions

  • the invention belongs to the technical field of traditional Chinese medicine, and in particular relates to an ultra-high performance liquid chromatography detection method for a traditional Chinese medicine composition.
  • the quality control method of traditional Chinese medicine compound preparation is mainly to qualitatively and quantitatively analyze the microscopic identification, examination and content determination of individual raw materials in the preparation.
  • traditional Chinese medicine compound preparations often include multi-flavored medicines, and some preparations even include animal medicines or mineral medicines, and the chemical composition thereof is far more complicated than single-flavor medicine.
  • more and more pharmaceutics researchers recognize that the use of microscopic identification, thin-layer chromatographic identification and quantitative analysis of a single indicator component is far from comprehensive and effective in reflecting the consistency and effectiveness of traditional Chinese medicine compound preparations. Since the first edition of the Chinese Pharmacopoeia in 2015, there has been a certain improvement in the quality control standards for traditional Chinese medicine compound preparations.
  • the quality control standard is unified for different quality control standards for the same preparation; thin layer identification is added for some traditional Chinese medicine preparations without thin layer identification (or thin layer identification is less, and thin layer identification is not for monarch) Indicators; determination of the content of multiple index components that are related to the efficacy of the original single indicator component; thin-layer scanning method for the determination of the content of the preparation has been reduced; enhanced gas chromatography for the application of volatiles
  • the traditional Chinese medicine compound preparations of sexual chemical composition, etc. the improvement of these quality control methods undoubtedly reflects the continuous improvement of the quality standards and quality control power of the traditional Chinese medicine compound preparations.
  • the quality evaluation and control of traditional Chinese medicine compound preparations is still a bottleneck that plagues the development and internationalization of traditional Chinese medicine. It is extremely urgent to carry out research on new quality assessment methods and methods for Chinese medicine compound preparations.
  • the traditional Chinese medicine composition of the invention is gathered in the famous name of the three dynasties, from forsythia, honeysuckle, ramie, fried almond, gypsum, radix scutellaria, Mianma Guanzhong, Houttuynia, patchouli, rhubarb, Rhodiola, menthol, licorice
  • the composition of 13 traditional Chinese medicines is complicated, and the preparation process includes water decoction, alcohol extract and volatile oil.
  • the quality standard contained in the 2015 edition of the Chinese Pharmacopoeia only the determination of forsythin is required. As a large compound preparation of traditional Chinese medicine, this is obviously not enough. How to better characterize the difference in the quality of traditional Chinese medicine compositions between batches, and to evaluate the quality of traditional Chinese medicine compositions by multi-component chemical rapid analysis is an urgent problem to be solved.
  • the object of the present invention is to provide a method for detecting a traditional Chinese medicine composition for the problem of the existing Chinese medicine compound reagent in characterizing the quality evaluation of drugs between different batches, and quantitatively determining by ultra performance liquid chromatography (UPLC).
  • UPLC ultra performance liquid chromatography
  • the main representative chemical components in the preparations are evaluated by multi-component chemical rapid analysis to better characterize the differences in the quality of traditional Chinese medicine compositions between batches.
  • the present invention provides a method for detecting a traditional Chinese medicine composition, the method comprising the following steps:
  • Step a preparing a test solution: taking a Chinese medicine composition, for example, a capsule content of a traditional Chinese medicine composition, and extracting by adding an organic solvent, thereby obtaining a test solution;
  • Step b preparation of the reference solution: taking chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin, dissolved in an organic solvent, that is, a control Product solution
  • Step c detection: using ultra performance liquid chromatography, using methanol (A)-phosphoric acid aqueous solution (B) as a mobile phase gradient elution;
  • the raw material composition of the traditional Chinese medicine composition is: 200-300 parts by weight of forsythia, 200-300 parts by weight of honeysuckle, 50-100 parts by weight of ramie, 50-100 parts by weight of fried almond, 200-300 parts by weight of gypsum, Ban GmbH 200 to 300 parts by weight, 200 to 300 parts by weight of Kumba, 200 to 300 parts by weight of Houttuynia, 50 to 100 parts by weight of patchouli, 20 to 70 parts by weight of rhubarb, 50 to 100 parts by weight of Rhodiola, 5 to 10 parts by weight of menthol and 50 to 100 parts by weight of licorice.
  • the raw material composition of the traditional Chinese medicine composition is: 255 parts by weight of forsythia, 255 parts by weight of honeysuckle, 85 parts by weight of ramie, 85 parts by weight of fried almond, 255 parts by weight of gypsum, 255 parts by weight of Radix Isatidis, 255 parts by weight of Phytosanitary, 255 parts by weight of Houttuynia cordata, 85 parts by weight of patchouli, 51 parts by weight of rhubarb, 85 parts by weight of Rhodiola, 7.5 parts by weight of menthol, and 85 parts by weight of licorice.
  • the raw materials of the traditional Chinese medicine composition can be made into different types of preparations.
  • different dosage forms may be selected for preparation, for example, but not limited to emulsifiable concentrate, wettable powder, suspending agent, granule, water-dispersible granule, microemulsion, water emulsion or micro Capsules, and so on.
  • the choice of each dosage form will depend on the materials or application of the traditional Chinese medicine composition; the corresponding preparation procedures are well known to those skilled in the art.
  • the raw material of the traditional Chinese medicine composition is made into a traditional Chinese medicine composition for detection.
  • the preparation method of the traditional Chinese medicine composition comprises the following steps:
  • the menthol and the volatile oil of the patchouli obtained in the step (1) are dissolved in ethanol, sprayed into the fine powder obtained in the step (3), and mixed; and the particles obtained after the step (3) are mixed, preferably. Also includes the operation of sealing for 20-30min;
  • the method further comprises the steps of: filling the preparation obtained in the step (4) into a capsule to prepare a capsule of the traditional Chinese medicine composition.
  • the traditional Chinese medicine composition or the traditional Chinese medicine composition capsule of the present invention can also be prepared by specifically referring to the preparation method of the traditional Chinese medicine composition described in the patent document No. 03143211.5.
  • the preparation method of the traditional Chinese medicine composition capsule comprises the following steps: the above thirteen flavors, patchouli and water distilled extract volatile oil, collecting volatile oil, filtering the water extract, and standby; forsythia , ramie, houttuynia, rhubarb with 70% ethanol extraction twice, the first 2 hours, the second 1.5 hours, the extract was filtered, combined, recovered ethanol, spare; honeysuckle, gypsum, Ban GmbH, Mian Ma Guan Add sautéed licorice, Rhodiola and Rhodiola to boiling, add fried almonds, and cook twice, the first 1.5 hours, the second time for 1 hour, the decoction is filtered, the filtrate is combined, and the patch is added to the patchouli oil.
  • the aqueous solution used is concentrated to a relative concentration of 1.10 to 1.15 (60 ° C), ethanol is added to make the alcohol content 70%, and refrigerated at 4 ° C for 24 hours, filtered, and the filtrate is recovered to recover ethanol, and the above-mentioned forsythia and other four flavors are reserved.
  • the alcohol extracts are combined, concentrated to a relative density of 1.10 ⁇ 1.15 (60 ° C), spray dried, mixed with an appropriate amount of starch, granulated, dried, sieved, sieved out a suitable amount of fine powder, menthol, patchouli volatile oil Dissolve with the right amount of ethanol, spray Powder, mixing, and mixing the granules, closed for 30 minutes into the capsule to prepare 1000, that is, too.
  • ultra-high performance liquid chromatography is used, and the methanol (A)-phosphoric acid aqueous solution (B) is used as a mobile phase gradient elution; respectively, the reference substance is aspirated.
  • the solution and the test solution are injected into an ultra-high performance liquid chromatograph for determination of chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin The content.
  • the gradient elution procedure is:
  • the gradient elution procedure is:
  • A as mentioned above means methanol in the mobile phase.
  • the percentage in the mobile phase of the present invention is a volume percentage, and the percentage of the aqueous phosphoric acid solution is a volume percentage.
  • the aqueous phosphoric acid solution has a concentration of 0.1% to 1%; more preferably 0.1% to 0.5%; still more preferably 0.1%.
  • the organic solvent in the step a is selected from any one or more of methanol, ethanol, acetone, dichloromethane and chloroform, preferably a 60% methanol solution.
  • the method of extracting in step a includes ultrasonic extraction or reflux extraction; more preferably, in the preparation of the test solution, the content of the capsule of the traditional Chinese medicine composition is mixed with the organic solvent of step a, Ultrasonic treatment or reflux extraction, followed by filtration, the resulting filtrate is the test solution.
  • the concentration of the test solution in step a is 10-20 mg/mL, more preferably 14 mg/mL.
  • concentration of the test solution as used herein refers to the volume ratio of the contents of the capsule of the traditional Chinese medicine composition or the capsule of the traditional Chinese medicine composition to the organic solvent used.
  • the organic solvent in the step b is selected from any one or more of methanol, ethanol, acetone, dichloromethane and chloroform, more preferably methanol.
  • the concentration of chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin in the reference solution of step b is 55-65 ⁇ g/ mL, 70-80 ⁇ g/mL, 65-72 ⁇ g/mL, 120-130 ⁇ g/mL, 60-70 ⁇ g/mL, 75-85 ⁇ g/mL, and 48-58 ⁇ g/mL.
  • the concentration of chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin in the reference solution is 60 ⁇ g/mL, 75 ⁇ g, respectively. /mL, 68 ⁇ g/mL, 125 ⁇ g/mL, 64 ⁇ g/mL, 80 ⁇ g/mL, 53 ⁇ g/mL.
  • the concentration of the reference solution refers to the volume ratio of the weight of chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin to the organic solvent used.
  • the detected detection wavelength is 200 to 250 nm, more preferably 210 nm; the injection amount is 1.0 to 2.0 ⁇ L; the flow rate is 0.10 to 0.50 mL/min; and the column temperature is 20 to 40 ° C.
  • the technical solution of the present invention has the beneficial effects that: (1) it is not enough to use only one component as a quality evaluation index in the traditional Chinese medicine composition; the present invention adopts ultra high performance liquid chromatography (UPLC). Simultaneous determination of 7 chemical components (chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin) in the preparation of traditional Chinese medicine composition, accuracy And high accuracy; the quality of the preparation is evaluated by multi-component chemical rapid analysis, which can better characterize the difference in the quality of the traditional Chinese medicine composition between batches; (2) the detection method of the present invention is increased relative to the method of the Pharmacopoeia
  • the components of chlorogenic acid, isochlorogenic acid B and isochlorogenic acid C, which are strongly related to biological activity, have established a method for detecting seven components in traditional Chinese medicine compositions, which can more fully characterize the composition of traditional Chinese medicines.
  • the invention utilizes the strong separation ability of ultra-
  • Example 1 is a UPLC chromatogram of the test solution of Example 1 according to chromatographic condition 1;
  • Figure 5 is a UPLC chromatogram of the mixed reference solution of Example 1 according to chromatographic condition 4;
  • Figure 6 is a UPLC chromatogram of the test solution according to the chromatographic condition 5 in Example 3;
  • Figure 7 is a UPLC chromatogram of the mixed reference solution in Example 3 according to chromatographic condition 5;
  • Figure 8 is a UPLC chromatogram of the test solution according to chromatographic condition 6 in Example 4.
  • Figure 9 is a UPLC chromatogram of the mixed reference solution in Example 4 according to chromatographic condition 6;
  • Figure 10 is a UPLC chromatogram of the test solution according to the chromatographic condition 7 in Example 5;
  • Figure 11 is a UPLC chromatogram of the mixed reference solution in Example 5 according to chromatographic conditions 7.
  • peak 1 is chlorogenic acid
  • peak 2 is caffeic acid
  • peak 3 is forsythiaside A
  • peak 4 is isochlorogenic acid B
  • peak 5 is rutin
  • the peak is isochlorogenic acid C
  • the peak No. 7 is forsythin.
  • the invention provides a method for detecting a traditional Chinese medicine composition, the method comprising the following steps:
  • Step a preparation of the test solution: taking the content of the traditional Chinese medicine composition, for example, the capsule of the traditional Chinese medicine composition, and extracting by adding an organic solvent, thereby obtaining a test solution;
  • Step b preparation of the reference solution: taking chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin, dissolved in an organic solvent, that is, a control Product solution
  • Step c detection: using ultra-high performance liquid chromatography, using methanol (A)-phosphoric acid aqueous solution (B) as a flow to the sample to be tested for gradient elution; separately taking the reference solution and the test solution, injecting super
  • the detection is carried out in a high performance liquid chromatograph, and the components to be tested include chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin;
  • the raw material composition of the traditional Chinese medicine composition is: 200-300 parts by weight of forsythia, 200-300 parts by weight of honeysuckle, 50-100 parts by weight of ramie, 50-100 parts by weight of fried almond, 200-300 parts by weight of gypsum, Ban GmbH 200 to 300 parts by weight, 200 to 300 parts by weight of Kumba, 200 to 300 parts by weight of Houttuynia, 50 to 100 parts by weight of patchouli, 20 to 70 parts by weight of rhubarb, 50 to 100 parts by weight of Rhodiola, 5 to 10 parts by weight of menthol and 50 to 100 parts by weight of licorice.
  • the raw material composition of the traditional Chinese medicine composition is: 255 parts by weight of forsythia, 255 parts by weight of honeysuckle, 85 parts by weight of ramie, 85 parts by weight of fried almond, 255 parts by weight of gypsum, 255 parts by weight of radix isatimus, 255 parts by weight of Guanzhong, 255 parts by weight of Houttuynia cordata, 85 parts by weight of patchouli, 51 parts by weight of rhubarb, 85 parts by weight of Rhodiola, 7.5 parts by weight of menthol, and 85 parts by weight of licorice.
  • the raw material of the traditional Chinese medicine composition is tested after being made into a traditional Chinese medicine composition.
  • the specific content described in the patent document No. 03143211.5 can be specifically referred to.
  • the gradient elution procedure is:
  • the gradient elution procedure is:
  • the gradient elution procedure is:
  • the concentration of the aqueous phosphoric acid solution is 0.1% to 1%, for example, 0.2%, 0.4%, 0.6%, 0.8%, 0.9%; preferably 0.1% to 0.5%. In a preferred embodiment, the concentration of the aqueous phosphoric acid solution is 0.1%.
  • "A" as seen above means methanol in the mobile phase, the percentage occurring in the mobile phase is a volume percentage, and the content percentage of "A" is 100 vol% based on the total volume of A + B. The percentage of the concentration in the aqueous phosphoric acid solution is a volume percentage. Further, the concentrations of the methanol solution and the ethanol solution appearing in the present invention are all volume concentrations.
  • the organic solvent of step a is selected from any one or more of methanol, ethanol, acetone, dichloromethane, and chloroform, preferably 60 vol% aqueous methanol.
  • the method of extracting in step a includes ultrasonic extraction or reflux extraction.
  • the test solution is prepared by mixing the traditional Chinese medicine composition with the organic solvent of step a, by sonication and filtration, and the obtained filtrate is the test solution.
  • the process of ultrasonic extraction is used, for example, taking the capsule content of the traditional Chinese medicine composition, grinding it into a fine powder by a mortar, taking about 0.35 g, accurately weighing, placing it in a 25 mL volumetric flask, precisely adding 60% methanol 20 mL, and sealing After weighing, weighed for 40 minutes (power 250W, frequency 40kHz); let cool, weighed the weight, make up the lost weight with 60% methanol, shake it, filter it with 0.22 ⁇ m microporous membrane, take The filtrate is continuously supplied, that is, the test solution is obtained.
  • the process of reflux extraction is adopted, for example, taking the capsule content of the traditional Chinese medicine composition, grinding it into a fine powder by a mortar, taking about 0.35 g, accurately weighing, placing it in a 25 mL volumetric flask, precisely adding 60% methanol 20 mL, and sealing After weighing, heat and reflux for 30 minutes; let cool, weigh the weight, make up the lost weight with 60% methanol, shake well, filter with 0.22 ⁇ m microporous membrane, take the filtrate, then you can test Product solution.
  • the concentration of the test solution in step a is 10-20 mg/mL, for example, 12 mg/mL, 13 mg/mL, 15 mg/mL, 17 mg/mL, 19 mg/mL, preferably. It is 14 mg/mL.
  • the organic solvent of step b is selected from any one or more of methanol, ethanol, acetone, dichloromethane, and chloroform, preferably methanol.
  • the reference solution in step b has a concentration of chlorogenic acid of 55-65 ⁇ g/mL, a concentration of caffeic acid of 70-80 ⁇ g/mL, and a concentration of rutin of 65-72 ⁇ g. /mL, the concentration of isochlorogenic acid B is 120-130 ⁇ g/mL, the concentration of isochlorogenic acid C is 60-70 ⁇ g/mL, the concentration of forsythiaside A is 75-85 ⁇ g/mL, and the concentration of forsythin It is 48 to 58 ⁇ g/mL.
  • the concentration of chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin in the reference solution is 60 ⁇ g/mL, 75 ⁇ g/ respectively.
  • the detection wavelength detected in the step c is 200 to 250 nm, for example, 220 nm, 230 nm, 240 nm, preferably 210 nm; the reference solution and the test solution as the detection target
  • the injection amount is 1.0 to 2.0 ⁇ L, for example, 1.2 ⁇ L, 1.5 ⁇ L, and 1.8 ⁇ L;
  • the flow rate is 0.10 to 0.50 mL/min, for example, 0.2 mL/min, 0.3 mL/min, 0.4 mL/min; and the column temperature is 20 ⁇ 40 ° C, for example, 30 ° C, 35 ° C.
  • composition of traditional Chinese medicine composition Forsythia 255g, Honeysuckle 255g, Castor Yellow 85g, Fried Bitter Almond 85g, Gypsum 255g, Radix Isatidis 255g, Mianma Guanzhong 255g, Houttuynia 255g, Patchouli 85g, Rhubarb 51g, Red View 85g, 7.5g of menthol, 85g of licorice.
  • the raw material of the traditional Chinese medicine composition is made into a capsule of a traditional Chinese medicine composition for detection.
  • the preparation method of the traditional Chinese medicine composition capsule comprises the following steps:
  • the alcohol content was 70 vol%, and the product was refrigerated at 4 ° C for 24 hours, filtered, and the ethanol was recovered to an alcohol-free taste; the obtained filtrate was further combined with the spare alcohol extract obtained in the step (3), and concentrated to a relative density of 1.15 (60 ° C). Clearing paste, spray drying; then mixing with appropriate amount of starch to make granules, drying, sieving, sieving out a suitable amount of fine powder;
  • Step a the preparation of the test solution is shown in the preparation of the liquid medicine of 2.2;
  • Step b the preparation of the reference solution is shown in the liquid preparation of 2.2;
  • Step c detection: using ultra-high performance liquid chromatography, using methanol (A)-phosphoric acid aqueous solution (B) as a mobile phase for gradient elution; taking the reference solution into an ultra-high performance liquid chromatograph for detection, drawing The standard curve of each reference solution is taken; the test solution is aspirated, injected into an ultra-high performance liquid chromatograph for detection, and the peak area of each component is taken into a standard curve to determine chlorogenic acid, caffeic acid, rutin, The content of isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin.
  • Chlorogenic acid (batch No. 151217, 99.68% for content determination), caffeic acid (batch No. 151103 for 99.40% for content determination), isochlorogenic acid B (batch number 15060708, for 98.82% for content determination) ), isochlorogenic acid C (batch 151028, 98.70% for content determination), forsythin (batch 15102801, 98.54% for content determination), forsythiaside A (lot 16082602, for content determination) Used in 99.17%), rutin (lot number 151023, 98.94% for content determination), provided by Chengdu Pfeide Biotechnology Co., Ltd.;
  • Chromatographic grade methanol, acetonitrile, chromatographic grade phosphoric acid (85% w/w) were purchased from Thermo Company, USA.
  • the column was a Waters Acquity HSS T3 column (2.1 ⁇ 100 mm, 1.7 ⁇ m), and the mobile phase was a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B).
  • the gradient elution procedure was:
  • 0.00–8.00 minutes 5-10% A; 8.01–15.00 minutes: 10-20% A; 15.01–20.00 minutes: 20-25% A; 20.01–25.00 minutes: 25-28% A; 25.01–30.00 minutes: 28 ⁇ 30%A; 30.01–35.00 minutes: 30 ⁇ 45%A; 35.01–40.00 minutes: 45 ⁇ 50%A; detection wavelength 210nm, injection volume 3.0 ⁇ L, flow rate 0.20mL/min, column temperature 30°C, column The balance time is 7 minutes.
  • the column was a Waters Acquity HSS T3 column (2.1 ⁇ 100 mm, 1.7 ⁇ m), and the mobile phase was a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B).
  • the gradient elution procedure was:
  • the column was a Waters Acquity HSS T3 column (2.1 ⁇ 100 mm, 1.7 ⁇ m), and the mobile phase was a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B).
  • the gradient elution procedure was:
  • the column was a Waters Acquity HSS T3 column (2.1 x 100 mm, 1.7 ⁇ m), and the mobile phase was a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B).
  • the gradient elution procedure was:
  • 0.00–8.00 minutes 15-20% A; 8.01–15.00 minutes: 20-24% A; 15.01–20.00 minutes: 24-30% A; 20.01–25.00 minutes: 30-34% A; 25.01–30.00 minutes: 34 ⁇ 40%A; 30.01–35.00 minutes: 40 ⁇ 50%A; 35.01–40.00 minutes: 50 ⁇ 60%A; detection wavelength 210nm, injection volume 2.0 ⁇ L, flow rate 0.20mL/min, column temperature 30°C, column The balance time is 7 minutes.
  • Preparation of reference solution accurately weigh chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin as reference substance, accurately weigh, set In a 25 mL brown volumetric flask, add 6 ⁇ g of chlorogenic acid, 75 ⁇ g of caffeic acid, 68 ⁇ g of rutin, 125 ⁇ g of isochlorogenic acid B, 64 ⁇ g of isochlorogenic acid C, 80 ⁇ g of forsythiaside A and 1 mL of methanol. A solution of 53 ⁇ g of forsythin, that is, a reference solution.
  • Preparation of the test solution Take the content of the capsule of the traditional Chinese medicine composition, research into a fine powder, about 0.35g, accurately weighed, placed in a 25mL volumetric flask, precision added 60vol% methanol 20mL, densely plug, weigh Determine the weight, sonicate for 40 minutes (power 250W, frequency 40kHz) for extraction, let cool, then weigh the weight, make up the lost weight with 60vol% methanol, shake well, filter with 0.22 ⁇ m microporous membrane, take out the filtrate , that is, the test solution is available.
  • the components to be tested cannot be completely separated.
  • the chromatographic conditions 4, 7 of the tested components chlorogenic acid, caffeic acid, rutin, and isochlorogenic
  • the resolution of the acid B, isochlorogenic acid C, forsythiaside A and forsythin, the number of theoretical plates and the tailing factor all meet the requirements for content determination.
  • the Chinese Pharmacopoeia stipulates that the qualified standard for the determination of capsules of traditional Chinese medicine composition is: containing at least 0.17 mg/granule of forsythin, and not less than 0.49 mg/g by the amount of 0.35 g/granule.
  • the results of the measurements in Table 2 indicate that 40 different batches of traditional Chinese medicine composition capsules (No. S01-S40) are all qualified; while the destructive samples A1, A2, A3 (No. S41-S43) have the content of forsythin.
  • the variation coefficient of chlorogenic acid, caffeic acid, forsythiaside A, isochlorogenic acid B, rutin, isochlorogenic acid C, forsythin content is 26%, 16%, 30%, 27%, 35%, 36%, 28%. It can be seen that it is not enough to use only one component of forsythin as a quality evaluation index.
  • the main representative chemical components in the preparation can be quantitatively determined, and the rapid analysis by multi-component chemistry is realized. To evaluate the quality of the formulation.
  • the present invention utilizes PCR technology to measure IL-6 and COX-2 in mouse lung tissue, and finds that the traditional Chinese medicine composition capsule of the present invention can significantly reduce virality
  • the expression of IL-6 and COX-2 in the lung tissue of pneumonia model mice was dose-dependent, and therefore, IL-6 and COX-2 were used as indicators for the biomass evaluation of the capsule quality of the traditional Chinese medicine composition of the present invention.
  • the content of seven chemical components (chlorogenic acid, rutin, forsythiaside A, forsythiaside, isochlorogenic acid C, isochlorogenic acid B, caffeic acid) in the traditional Chinese medicine composition is an independent variable.
  • the potency is the dependent variable.
  • the statistical analysis samples were taken to investigate the inhibition of COX-2 biopotency, inhibition of macrophage secretion of IL-6 biopotency and 7 chemical components. Correlation analysis of the results of the content determination was performed using multivariate statistical SPSS statistical software. The results are shown in Table 3.
  • the related components were chlorogenic acid, isochlorogenic acid B, isochlorogenic acid C and other acid components, and were positively correlated (p ⁇ 0.05). It is suggested that the higher the content of these three components, the higher the level of inhibition of COX-2 enzyme activity. Therefore, in the case where the detection method of the present invention can realize the content and quality detection of the seven components, the detection of the index component which increases the correlation activity of the chemical composition of the capsule of the traditional Chinese medicine composition further improves the traditional Chinese medicine to a certain extent. The ability to assess the consistency of composition quality.
  • the detection method of the invention increases the component indexes of chlorogenic acid, isochlorogenic acid B and isochlorogenic acid C which are highly correlated with biological activity, and establishes 7 components in the traditional Chinese medicine composition.
  • the detection method can more fully characterize the quality of the traditional Chinese medicine composition.
  • the preparation method and detection method of the composition of the traditional Chinese medicine composition and the capsule of the traditional Chinese medicine composition are the same as those in the first embodiment; the detection is performed according to the chromatographic condition 5: the column is a Waters Acquity HSS T3 column (2.1 ⁇ 100 mm, 1.7 ⁇ m).
  • the mobile phase is a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B).
  • the gradient elution procedure is:
  • Preparation of reference solution accurately weigh chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin reference substance, accurately weighed, placed In a 25 mL brown volumetric flask, a solution containing 60 ⁇ g, 75 ⁇ g, 68 ⁇ g, 125 ⁇ g, 64 ⁇ g, 80 ⁇ g, and 53 ⁇ g per 1 mL was added to obtain a reference solution.
  • Preparation of the test solution Take the content of the traditional Chinese medicine composition capsule (No. S40), research into a fine powder, about 0.35g, accurately weighed, placed in a 25mL volumetric flask, precisely added 60% methanol 20mL, Concealed, weighed, sonicated for 40 minutes (power 250W, frequency 40kHz), let cool, then weighed, with 60% methanol to make up the lost weight, shake, filtered through a 0.22 ⁇ m microporous membrane, The filtrate is taken to obtain the test solution.
  • the traditional Chinese medicine composition capsule No. S40
  • the preparation method and detection method of the prescription of the traditional Chinese medicine composition and the capsule of the traditional Chinese medicine composition are the same as those in the first embodiment; the detection is performed according to the chromatographic condition 6: the column is a Waters Acquity HSS T3 column (2.1 ⁇ 100 mm, 1.7 ⁇ m).
  • the mobile phase is a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B).
  • the gradient elution procedure is:
  • 0.00–8.00 minutes 16-18% A; 8.01–15.00 minutes: 18 to 25% A; 15.01–20.00 minutes: 25 to 28% A; 20.01–25.00 minutes: 28 to 32% A; 25.01–30.00 minutes: 32 ⁇ 42%A; 30.01–35.00 minutes: 42 ⁇ 48%A; 35.01–40.00 minutes: 48 ⁇ 58%A; detection wavelength 210nm, injection volume 2.0 ⁇ L, flow rate 0.20mL/min, column temperature 30°C, column The balance time is 7 minutes.
  • Preparation of reference solution accurately weigh chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin reference substance, accurately weighed, placed In a 25 mL brown volumetric flask, a solution containing 60 ⁇ g, 75 ⁇ g, 68 ⁇ g, 125 ⁇ g, 64 ⁇ g, 80 ⁇ g, and 53 ⁇ g per 1 mL was added to obtain a reference solution.
  • Preparation of the test solution Take the content of the capsule of the traditional Chinese medicine composition (No. S40), research into a fine powder, take about 0.35g, accurately weigh it, place it in a 25mL volumetric flask, and accurately add 60mL methanol to 20mL. Concealed, weighed, sonicated for 40 minutes (power 250W, frequency 40kHz), let cool, then weighed, with 60% methanol to make up the lost weight, shake, filtered through a 0.22 ⁇ m microporous membrane, The filtrate is taken to obtain the test solution.
  • No. S40 traditional Chinese medicine composition
  • the preparation method and the detection method of the prescription of the traditional Chinese medicine composition and the capsule of the traditional Chinese medicine composition are the same as those in the first embodiment; the difference is that the chromatography column is the waters Acquity HSS T3 column (2.1 ⁇ 100 mm, 1.7 ⁇ m).
  • the mobile phase is a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B).
  • the gradient elution procedure is:
  • 0.00–8.00 minutes 14-20% A; 8.01–15.00 minutes: 20-25% A; 15.01–20.00 minutes: 25-30% A; 20.01–25.00 minutes: 30-35% A; 25.01–30.00 minutes: 35 ⁇ 42%A; 30.01–35.00 minutes: 42 ⁇ 51%A; 35.01–40.00 minutes: 51 ⁇ 60%A; detection wavelength 210nm, injection volume 2.0 ⁇ L, flow rate 0.20mL/min, column temperature 30°C, column The balance time is 7 minutes.
  • Preparation of reference solution accurately weigh chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin reference substance, accurately weighed, placed In a 25 mL brown volumetric flask, a solution containing 60 ⁇ g, 75 ⁇ g, 68 ⁇ g, 125 ⁇ g, 64 ⁇ g, 80 ⁇ g, and 53 ⁇ g per 1 mL was added to obtain a reference solution.
  • Preparation of the test solution Take the content of the capsule of the traditional Chinese medicine composition (No. S40), research into a fine powder, take about 0.35g, accurately weigh it, place it in a 25mL volumetric flask, and accurately add 60mL methanol to 20mL. Concealed, weighed, sonicated for 40 minutes (power 250W, frequency 40kHz), let cool, then weighed, with 60% methanol to make up the lost weight, shake, filtered through a 0.22 ⁇ m microporous membrane, The filtrate is taken to obtain the test solution.
  • No. S40 traditional Chinese medicine composition
  • Example 1 The results showed that the components to be tested could not be completely separated according to the chromatographic conditions 1, 2, and 3.
  • seven of the components to be tested chlorogenic acid, caffeic acid
  • the separation degree, theoretical plate number and tailing factor of rutin, chlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin all meet the requirements for content determination, and the system has good applicability.
  • Example 3-5 was examined according to the chromatographic conditions 5-7. The separation degree, the number of theoretical plates, and the tailing factor of the seven components in the test results all met the requirements for content determination.

Abstract

An ultra-high-performance liquid chromatography detection method for a traditional Chinese medicine (TCM) composition. The detection method comprises the following steps: step A, preparation of a test sample solution: collecting the content of a TCM composition capsule and adding an organic solvent for extraction so as to obtain the test sample solution; step B, preparation of a control solution: collecting chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin and adding an organic solvent to dissolve so as to obtain the control solution; and step C, detection: using ultra-high-performance liquid chromatography with methanol (A) and water containing phosphate (B) as mobile phases for gradient elution. The ultra-high-performance liquid chromatography can quantitatively determine seven chemical components in a composition, such that the quality of the composition is evaluated by means of said fast multi-component chemical analysis, thereby achieving better characterization of quality differences between batches of TCM composition capsules.

Description

一种中药组合物的超高效液相色谱检测方法Ultra high performance liquid chromatography method for detecting traditional Chinese medicine composition 技术领域Technical field
本发明属于中医药技术领域,尤其涉及一种中药组合物的超高效液相色谱检测方法。The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to an ultra-high performance liquid chromatography detection method for a traditional Chinese medicine composition.
背景技术Background technique
中药复方制剂的质量控制手段主要是对制剂中个别原药材的显微鉴别、检查、含量测定等进行定性和定量分析。然而中药复方制剂往往是包括多味药材,有的制剂中甚至包括动物药或矿物药,其所含的化学成分的复杂程度远远超过了单味药材。实际上,越来越多的药学研究者认识到利用显微鉴别、薄层色谱鉴别和单一指标性成分的定量分析远远不能全面有效的反映中药复方制剂质量一致性和有效性。从2015年版《中国药典》一部开始,对于中药复方制剂的质量控制标准已经有了一定的提高。例如,对于同一制剂具有不同质控标准统一了质量控制标准;对于一些无薄层鉴别项(或者薄层鉴别较少、已薄层鉴别项不是针对君药)的中药复方制剂增加了薄层鉴别指标;由原来的单一指标性成分含量测定增加为关联药效的多个指标性成分的含量测定;薄层扫描法用于含量测定的制剂品种有所减少;加强了气相色谱法应用于含挥发性化学成分的中药复方制剂等等;这些质量控制方法的改进无疑体现了中药复方制剂的质量标准和质量控制力在不断的提高。但是中药复方制剂的质量评价与控制问题仍然是困扰中医药发展和国际化的一个瓶颈,开展中药复方制剂新的质量评控模式和方法研究迫在眉睫。The quality control method of traditional Chinese medicine compound preparation is mainly to qualitatively and quantitatively analyze the microscopic identification, examination and content determination of individual raw materials in the preparation. However, traditional Chinese medicine compound preparations often include multi-flavored medicines, and some preparations even include animal medicines or mineral medicines, and the chemical composition thereof is far more complicated than single-flavor medicine. In fact, more and more pharmaceutics researchers recognize that the use of microscopic identification, thin-layer chromatographic identification and quantitative analysis of a single indicator component is far from comprehensive and effective in reflecting the consistency and effectiveness of traditional Chinese medicine compound preparations. Since the first edition of the Chinese Pharmacopoeia in 2015, there has been a certain improvement in the quality control standards for traditional Chinese medicine compound preparations. For example, the quality control standard is unified for different quality control standards for the same preparation; thin layer identification is added for some traditional Chinese medicine preparations without thin layer identification (or thin layer identification is less, and thin layer identification is not for monarch) Indicators; determination of the content of multiple index components that are related to the efficacy of the original single indicator component; thin-layer scanning method for the determination of the content of the preparation has been reduced; enhanced gas chromatography for the application of volatiles The traditional Chinese medicine compound preparations of sexual chemical composition, etc.; the improvement of these quality control methods undoubtedly reflects the continuous improvement of the quality standards and quality control power of the traditional Chinese medicine compound preparations. However, the quality evaluation and control of traditional Chinese medicine compound preparations is still a bottleneck that plagues the development and internationalization of traditional Chinese medicine. It is extremely urgent to carry out research on new quality assessment methods and methods for Chinese medicine compound preparations.
本发明中药组合物汇聚三朝名方,由连翘、金银花、炙麻黄、炒苦杏仁、石膏、板蓝根、绵马贯众、鱼腥草、广藿香、大黄、红景天、薄荷脑、甘草13味中药组方而成,制备工艺比较复杂,入药形式包括水煎液、醇提液和挥发油。在2015版《中国药典》收载的质量标准中仅仅要求对连翘苷进行含量测定,作为一个中药大复方制剂,这显然是不够的。如何能够更好的表征不同批次间中药组合物质量的差异性、通过多组分化学快速分析来评价中药组合物的质量,是目前急需解决的问题。The traditional Chinese medicine composition of the invention is gathered in the famous name of the three dynasties, from forsythia, honeysuckle, ramie, fried almond, gypsum, radix scutellaria, Mianma Guanzhong, Houttuynia, patchouli, rhubarb, Rhodiola, menthol, licorice The composition of 13 traditional Chinese medicines is complicated, and the preparation process includes water decoction, alcohol extract and volatile oil. In the quality standard contained in the 2015 edition of the Chinese Pharmacopoeia, only the determination of forsythin is required. As a large compound preparation of traditional Chinese medicine, this is obviously not enough. How to better characterize the difference in the quality of traditional Chinese medicine compositions between batches, and to evaluate the quality of traditional Chinese medicine compositions by multi-component chemical rapid analysis is an urgent problem to be solved.
发明内容Summary of the invention
本发明的目的在于,针对现有中药复方试剂在表征不同批次间药物的质量评控中存在 的问题,提供一种中药组合物的检测方法,采用超高效液相色谱法(UPLC)定量测定制剂中的主要代表性化学成分,通过多组分化学快速分析来评价制剂的质量,能够更好的表征不同批次间中药组合物质量的差异性。The object of the present invention is to provide a method for detecting a traditional Chinese medicine composition for the problem of the existing Chinese medicine compound reagent in characterizing the quality evaluation of drugs between different batches, and quantitatively determining by ultra performance liquid chromatography (UPLC). The main representative chemical components in the preparations are evaluated by multi-component chemical rapid analysis to better characterize the differences in the quality of traditional Chinese medicine compositions between batches.
为了实现上述目的,本发明提供一种中药组合物的检测方法,所述检测方法包括如下步骤:In order to achieve the above object, the present invention provides a method for detecting a traditional Chinese medicine composition, the method comprising the following steps:
步骤a,供试品溶液的制备:取中药组合物,例如中药组合物胶囊剂内容物,加入有机溶剂提取,即得供试品溶液;Step a, preparing a test solution: taking a Chinese medicine composition, for example, a capsule content of a traditional Chinese medicine composition, and extracting by adding an organic solvent, thereby obtaining a test solution;
步骤b,对照品溶液的制备:取绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷,加入有机溶剂溶解,即得对照品溶液;Step b, preparation of the reference solution: taking chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin, dissolved in an organic solvent, that is, a control Product solution
步骤c,检测:采用超高效液相色谱法,以甲醇(A)-磷酸水溶液(B)为流动相梯度洗脱;Step c, detection: using ultra performance liquid chromatography, using methanol (A)-phosphoric acid aqueous solution (B) as a mobile phase gradient elution;
其中,中药组合物的原料组成为:连翘200~300重量份、金银花200~300重量份、炙麻黄50~100重量份、炒苦杏仁50~100重量份、石膏200~300重量份、板蓝根200~300重量份、绵马贯众200~300重量份、鱼腥草200~300重量份、广藿香50~100重量份、大黄20~70重量份、红景天50~100重量份、薄荷脑5~10重量份、甘草50~100重量份。The raw material composition of the traditional Chinese medicine composition is: 200-300 parts by weight of forsythia, 200-300 parts by weight of honeysuckle, 50-100 parts by weight of ramie, 50-100 parts by weight of fried almond, 200-300 parts by weight of gypsum, Banlangen 200 to 300 parts by weight, 200 to 300 parts by weight of Kumba, 200 to 300 parts by weight of Houttuynia, 50 to 100 parts by weight of patchouli, 20 to 70 parts by weight of rhubarb, 50 to 100 parts by weight of Rhodiola, 5 to 10 parts by weight of menthol and 50 to 100 parts by weight of licorice.
根据本发明提供的检测方法,优选地,所述中药组合物的原料组成为:连翘255重量份、金银花255重量份、炙麻黄85重量份、炒苦杏仁85重量份、石膏255重量份、板蓝根255重量份、绵马贯众255重量份、鱼腥草255重量份、广藿香85重量份、大黄51重量份、红景天85重量份、薄荷脑7.5重量份、甘草85重量份。According to the detection method provided by the present invention, preferably, the raw material composition of the traditional Chinese medicine composition is: 255 parts by weight of forsythia, 255 parts by weight of honeysuckle, 85 parts by weight of ramie, 85 parts by weight of fried almond, 255 parts by weight of gypsum, 255 parts by weight of Radix Isatidis, 255 parts by weight of Phytosanitary, 255 parts by weight of Houttuynia cordata, 85 parts by weight of patchouli, 51 parts by weight of rhubarb, 85 parts by weight of Rhodiola, 7.5 parts by weight of menthol, and 85 parts by weight of licorice.
本领域技术人员可以理解,可以将中药组合物的原料制成不同类型的制剂。在中药组合物制剂的制备过程中,可选择不同的剂型进行制备,例如,可选自但不限于乳油、可湿性粉剂、悬浮剂、颗粒剂、水分散粒剂、微乳剂、水乳剂或微胶囊剂,等等。各剂型的选择可根据中药组合物的原料或者应用而定;相对应的制备过程为本领域技术人员所熟知。It will be understood by those skilled in the art that the raw materials of the traditional Chinese medicine composition can be made into different types of preparations. In the preparation of the preparation of the traditional Chinese medicine composition, different dosage forms may be selected for preparation, for example, but not limited to emulsifiable concentrate, wettable powder, suspending agent, granule, water-dispersible granule, microemulsion, water emulsion or micro Capsules, and so on. The choice of each dosage form will depend on the materials or application of the traditional Chinese medicine composition; the corresponding preparation procedures are well known to those skilled in the art.
根据本发明提供的检测方法,优选地,将所述中药组合物的原料制成中药组合物进行检测。According to the detection method provided by the present invention, preferably, the raw material of the traditional Chinese medicine composition is made into a traditional Chinese medicine composition for detection.
优选地,所述中药组合物的制备方法包括如下步骤:Preferably, the preparation method of the traditional Chinese medicine composition comprises the following steps:
(1)广藿香加水蒸馏提取挥发油,收集挥发油;将水溶液过滤后,得到滤液;(1) extracting volatile oil from patchouli and adding water to collect volatile oil; filtering the aqueous solution to obtain a filtrate;
(2)将连翘、炙麻黄、鱼腥草、大黄用70vol%乙醇提取,再将提取液过滤后,回收乙醇,得到醇提取液;(2) extracting forsythia, ramie, houttuynia, rhubarb with 70 vol% ethanol, filtering the extract, and recovering the ethanol to obtain an alcohol extract;
(3)将金银花、石膏、板蓝根、绵马贯众、甘草、红景天加水煎煮至沸,加入炒苦杏仁煎煮,再将煎煮所得煎液过滤得到的滤液中加入步骤(1)广藿香提油、过滤后的滤液,浓缩至相对浓度为1.10~1.15,加乙醇使含醇量达70vol%,在2-4℃冷藏20-24小时,过滤,滤液回收乙醇后与步骤(2)所得连翘等四味中药的醇提取液合并,浓缩至相对密度为1.10~1.15,喷雾干燥;再与淀粉混匀使其制成颗粒,干燥、过筛,筛出细粉;(3) Add honeysuckle, gypsum, Banlangen, Mianmaguanzhong, licorice, Rhodiola to boil, add frying almonds, and add the filtrate obtained by decoction to the filtrate (1). The patchouli oil and the filtered filtrate are concentrated to a relative concentration of 1.10 to 1.15, ethanol is added to make the alcohol content 70 vol%, refrigerated at 2-4 ° C for 20-24 hours, filtered, and the filtrate is recovered and the step is recovered. 2) The obtained alcohol extracts of four traditional Chinese medicines such as Forsythia are combined, concentrated to a relative density of 1.10 to 1.15, spray-dried; then mixed with starch to make granules, dried, sieved, and sieved to a fine powder;
(4)将薄荷脑、步骤(1)所得广藿香挥发油用乙醇溶解后,喷至步骤(3)所得细粉中并混匀;再与步骤(3)过筛后所得颗粒混匀,优选还包括密闭20-30min的操作;(4) The menthol and the volatile oil of the patchouli obtained in the step (1) are dissolved in ethanol, sprayed into the fine powder obtained in the step (3), and mixed; and the particles obtained after the step (3) are mixed, preferably. Also includes the operation of sealing for 20-30min;
进一步优选还包括如下操作:将步骤(4)所得制剂装入胶囊,制成中药组合物胶囊剂。Further preferably, the method further comprises the steps of: filling the preparation obtained in the step (4) into a capsule to prepare a capsule of the traditional Chinese medicine composition.
本发明所述中药组合物或中药组合物胶囊剂还可具体参考申请号为03143211.5的专利文件中记载的中药组合物制备方法进行制备。The traditional Chinese medicine composition or the traditional Chinese medicine composition capsule of the present invention can also be prepared by specifically referring to the preparation method of the traditional Chinese medicine composition described in the patent document No. 03143211.5.
例如,在一些具体实施方式中,所述中药组合物胶囊剂的制备方法包括如下步骤:以上十三味,广藿香加水蒸馏提取物挥发油,收集挥发油,水提取液滤过,备用;连翘、炙麻黄、鱼腥草、大黄用70%乙醇提取二次,第一次2小时,第二次1.5小时,提取液滤过,合并,回收乙醇,备用;金银花、石膏、板蓝根、绵马贯众、甘草、红景天加水煎煮至沸,加入炒苦杏仁,煎煮二次,第一次1.5小时,第二次1小时,煎液滤过,滤液合并,加入广藿香提油后备用的水溶液,浓缩至相对浓度为1.10~1.15(60℃),加乙醇使含醇量达70%,在4℃冷藏24小时,滤过,滤液回收乙醇,与上述连翘等四味的备用醇提取液合并,浓缩至相对密度为1.10~1.15(60℃),喷雾干燥,与适量淀粉混匀,制成颗粒,干燥,过筛,筛出适量细粉,将薄荷脑、广藿香挥发油用适量乙醇溶解,喷入细粉中,混匀,与上述颗粒混匀,密闭30分钟,装入胶囊,制成1000粒,即得。For example, in some embodiments, the preparation method of the traditional Chinese medicine composition capsule comprises the following steps: the above thirteen flavors, patchouli and water distilled extract volatile oil, collecting volatile oil, filtering the water extract, and standby; forsythia , ramie, houttuynia, rhubarb with 70% ethanol extraction twice, the first 2 hours, the second 1.5 hours, the extract was filtered, combined, recovered ethanol, spare; honeysuckle, gypsum, Banlangen, Mian Ma Guan Add sautéed licorice, Rhodiola and Rhodiola to boiling, add fried almonds, and cook twice, the first 1.5 hours, the second time for 1 hour, the decoction is filtered, the filtrate is combined, and the patch is added to the patchouli oil. The aqueous solution used is concentrated to a relative concentration of 1.10 to 1.15 (60 ° C), ethanol is added to make the alcohol content 70%, and refrigerated at 4 ° C for 24 hours, filtered, and the filtrate is recovered to recover ethanol, and the above-mentioned forsythia and other four flavors are reserved. The alcohol extracts are combined, concentrated to a relative density of 1.10~1.15 (60 ° C), spray dried, mixed with an appropriate amount of starch, granulated, dried, sieved, sieved out a suitable amount of fine powder, menthol, patchouli volatile oil Dissolve with the right amount of ethanol, spray Powder, mixing, and mixing the granules, closed for 30 minutes into the capsule to prepare 1000, that is, too.
根据本发明提供的检测方法,优选地,步骤c的检测过程中,采用超高效液相色谱法,以甲醇(A)-磷酸水溶液(B)为流动相梯度洗脱;分别吸取所述对照品溶液和供试品溶液,注入超高效液相色谱仪中进行检测,测定绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷的含量。According to the detection method provided by the present invention, preferably, in the detection process of step c, ultra-high performance liquid chromatography is used, and the methanol (A)-phosphoric acid aqueous solution (B) is used as a mobile phase gradient elution; respectively, the reference substance is aspirated. The solution and the test solution are injected into an ultra-high performance liquid chromatograph for determination of chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin The content.
根据本发明提供的检测方法,优选地,所述梯度洗脱的程序为:According to the detection method provided by the present invention, preferably, the gradient elution procedure is:
时间/minTime/min A/%A/%
0.000.00 12~1612 to 16
8.008.00 18~2018~20
15.0015.00 22~2522~25
20.0020.00 28~3028~30
25.0025.00 32~3532~35
30.0030.00 38~4338~43
35.0035.00 48~5248~52
40.0040.00 55~6055~60
更优选地,所述梯度洗脱的程序为:More preferably, the gradient elution procedure is:
时间/minTime/min A/%A/%
0.000.00 1515
8.008.00 2020
15.0015.00 24twenty four
20.0020.00 3030
25.0025.00 3434
30.0030.00 4040
35.0035.00 5050
40.0040.00 6060
其中,如上出现的“A”是指流动相中的甲醇。本发明流动相中的百分比为体积百分比,所述磷酸水溶液的百分比为体积百分比。Among them, "A" as mentioned above means methanol in the mobile phase. The percentage in the mobile phase of the present invention is a volume percentage, and the percentage of the aqueous phosphoric acid solution is a volume percentage.
优选地,所述磷酸水溶液浓度为0.1%~1%;更优选为0.1%~0.5%;更进一步优选为0.1%。Preferably, the aqueous phosphoric acid solution has a concentration of 0.1% to 1%; more preferably 0.1% to 0.5%; still more preferably 0.1%.
根据本发明提供的检测方法,优选地,步骤a所述有机溶剂选自甲醇、乙醇、丙酮、二氯甲烷和三氯甲烷中的任意一种或几种,优选为60%的甲醇溶液。According to the detection method provided by the present invention, preferably, the organic solvent in the step a is selected from any one or more of methanol, ethanol, acetone, dichloromethane and chloroform, preferably a 60% methanol solution.
优选地,步骤a所述提取的方法包括超声提取或回流提取;更优选地,所述供试品溶液的制备中,将中药组合物胶囊剂的内容物与步骤a所述有机溶剂混合,通过超声处理或回流提取,之后过滤,所得滤液即为供试品溶液。Preferably, the method of extracting in step a includes ultrasonic extraction or reflux extraction; more preferably, in the preparation of the test solution, the content of the capsule of the traditional Chinese medicine composition is mixed with the organic solvent of step a, Ultrasonic treatment or reflux extraction, followed by filtration, the resulting filtrate is the test solution.
优选地,步骤a供试品溶液的浓度为10~20mg/mL,更优选为14mg/mL。这里所述供试品溶液的浓度是指中药组合物或者中药组合物胶囊剂的内容物重量与所用有机溶剂的体 积比。Preferably, the concentration of the test solution in step a is 10-20 mg/mL, more preferably 14 mg/mL. The concentration of the test solution as used herein refers to the volume ratio of the contents of the capsule of the traditional Chinese medicine composition or the capsule of the traditional Chinese medicine composition to the organic solvent used.
根据本发明提供的检测方法,优选地,步骤b所述有机溶剂选自甲醇、乙醇、丙酮、二氯甲烷和三氯甲烷中的任意一种或几种,更优选为甲醇。According to the detection method provided by the present invention, preferably, the organic solvent in the step b is selected from any one or more of methanol, ethanol, acetone, dichloromethane and chloroform, more preferably methanol.
优选地,步骤b所述对照品溶液中绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷的浓度分别为55~65μg/mL、70~80μg/mL、65~72μg/mL、120~130μg/mL、60~70μg/mL、75~85μg/mL和48~58μg/mL。更优选的,所述对照品溶液中绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷的浓度分别为60μg/mL、75μg/mL、68μg/mL、125μg/mL、64μg/mL、80μg/mL、53μg/mL。这里对照品溶液的浓度是指绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷的重量与所用有机溶剂的体积比。Preferably, the concentration of chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin in the reference solution of step b is 55-65 μg/ mL, 70-80 μg/mL, 65-72 μg/mL, 120-130 μg/mL, 60-70 μg/mL, 75-85 μg/mL, and 48-58 μg/mL. More preferably, the concentration of chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin in the reference solution is 60 μg/mL, 75 μg, respectively. /mL, 68 μg/mL, 125 μg/mL, 64 μg/mL, 80 μg/mL, 53 μg/mL. Here, the concentration of the reference solution refers to the volume ratio of the weight of chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin to the organic solvent used.
根据本发明提供的检测方法,优选地,所述检测的检测波长为200~250nm,更优选为210nm;进样量为1.0~2.0μL;流速为0.10~0.50mL/min;柱温为20~40℃。According to the detection method provided by the present invention, preferably, the detected detection wavelength is 200 to 250 nm, more preferably 210 nm; the injection amount is 1.0 to 2.0 μL; the flow rate is 0.10 to 0.50 mL/min; and the column temperature is 20 to 40 ° C.
本发明中,待测成分的结构式如表1所示:In the present invention, the structural formula of the component to be tested is as shown in Table 1:
表1 待测成分结构式Table 1 Structure of the component to be tested
Figure PCTCN2018110123-appb-000001
Figure PCTCN2018110123-appb-000001
Figure PCTCN2018110123-appb-000002
Figure PCTCN2018110123-appb-000002
与现有技术相比,本发明技术方案的有益效果在于:(1)中药组合物中仅以一种成分作为质量评价指标是远远不够的;本发明采用超高效液相色谱法(UPLC)可以同时定量测定中药组合物制剂中的7个化学成分(绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷),精确度和准确度高;通过多组分化学快速分析来评价制剂的质量,能够更好的表征不同批次间中药组合物质量的差异性;(2)本发明检测方法相对于《药典》的方法增加了与生物活性相关性强的绿原酸、异绿原酸B、异绿原酸C的成分指标,建立了对中药组合物中7种成分的检测方法,能更全面的表征中药组合物的质量;(3)本发明利用超高效液相色谱强大的分离能力,能够较好的将成分复杂的中药组合物中目标峰和杂质峰分离,得到较好的分离度。Compared with the prior art, the technical solution of the present invention has the beneficial effects that: (1) it is not enough to use only one component as a quality evaluation index in the traditional Chinese medicine composition; the present invention adopts ultra high performance liquid chromatography (UPLC). Simultaneous determination of 7 chemical components (chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin) in the preparation of traditional Chinese medicine composition, accuracy And high accuracy; the quality of the preparation is evaluated by multi-component chemical rapid analysis, which can better characterize the difference in the quality of the traditional Chinese medicine composition between batches; (2) the detection method of the present invention is increased relative to the method of the Pharmacopoeia The components of chlorogenic acid, isochlorogenic acid B and isochlorogenic acid C, which are strongly related to biological activity, have established a method for detecting seven components in traditional Chinese medicine compositions, which can more fully characterize the composition of traditional Chinese medicines. (3) The invention utilizes the strong separation ability of ultra-high performance liquid chromatography, and can better separate the target peak and the impurity peak in the complex Chinese medicine composition, and obtain better resolution.
附图说明DRAWINGS
图1为实施例1的供试品溶液按色谱条件①的UPLC色谱图;1 is a UPLC chromatogram of the test solution of Example 1 according to chromatographic condition 1;
图2为实施例1的供试品溶液按色谱条件②的UPLC色谱图;2 is a UPLC chromatogram of the test solution of Example 1 according to chromatographic condition 2;
图3为实施例1的供试品溶液按色谱条件③的UPLC色谱图;3 is a UPLC chromatogram of the test solution of Example 1 according to chromatographic condition 3;
图4为实施例1的供试品溶液按色谱条件④的UPLC色谱图;4 is a UPLC chromatogram of the test solution of Example 1 according to chromatographic condition 4;
图5为实施例1的混合对照品溶液按色谱条件④的UPLC色谱图;Figure 5 is a UPLC chromatogram of the mixed reference solution of Example 1 according to chromatographic condition 4;
图6为实施例3中供试品溶液按色谱条件⑤的UPLC色谱图;Figure 6 is a UPLC chromatogram of the test solution according to the chromatographic condition 5 in Example 3;
图7为实施例3中混合对照品溶液按色谱条件⑤的UPLC色谱图;Figure 7 is a UPLC chromatogram of the mixed reference solution in Example 3 according to chromatographic condition 5;
图8为实施例4中供试品溶液按色谱条件⑥的UPLC色谱图;Figure 8 is a UPLC chromatogram of the test solution according to chromatographic condition 6 in Example 4;
图9为实施例4中混合对照品溶液按色谱条件⑥的UPLC色谱图;Figure 9 is a UPLC chromatogram of the mixed reference solution in Example 4 according to chromatographic condition 6;
图10为实施例5中供试品溶液按色谱条件⑦的UPLC色谱图;Figure 10 is a UPLC chromatogram of the test solution according to the chromatographic condition 7 in Example 5;
图11为实施例5中混合对照品溶液按色谱条件⑦的UPLC色谱图。Figure 11 is a UPLC chromatogram of the mixed reference solution in Example 5 according to chromatographic conditions 7.
在图1-11中,1号峰为绿原酸;2号峰为咖啡酸;3号峰为连翘酯苷A;4号峰为异绿原酸B;5号峰为芦丁;6号峰为异绿原酸C;7号峰为连翘苷。In Figure 1-11, peak 1 is chlorogenic acid; peak 2 is caffeic acid; peak 3 is forsythiaside A; peak 4 is isochlorogenic acid B; peak 5 is rutin; The peak is isochlorogenic acid C; the peak No. 7 is forsythin.
具体实施方式Detailed ways
为了进一步了解本发明,下面结合实施例对本发明具体实施方案进行描述,但是应当理解,这些描述只是为进一步说明本发明的特征和优点,而不是对本发明权利要求的限制。The present invention will be described in detail with reference to the preferred embodiments of the invention.
本发明提供一种中药组合物的检测方法,所述方法包括如下步骤:The invention provides a method for detecting a traditional Chinese medicine composition, the method comprising the following steps:
步骤a,供试品溶液的制备:取中药组合物,例如中药组合物胶囊剂的内容物,加入有机溶剂提取,即得供试品溶液;Step a, preparation of the test solution: taking the content of the traditional Chinese medicine composition, for example, the capsule of the traditional Chinese medicine composition, and extracting by adding an organic solvent, thereby obtaining a test solution;
步骤b,对照品溶液的制备:取绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷,加入有机溶剂溶解,即得对照品溶液;Step b, preparation of the reference solution: taking chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin, dissolved in an organic solvent, that is, a control Product solution
步骤c,检测:采用超高效液相色谱法,以甲醇(A)-磷酸水溶液(B)为流动相对待测样品进行梯度洗脱;分别吸取所述对照品溶液和供试品溶液,注入超高效液相色谱仪中进行检测,待测成分包括绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷;Step c, detection: using ultra-high performance liquid chromatography, using methanol (A)-phosphoric acid aqueous solution (B) as a flow to the sample to be tested for gradient elution; separately taking the reference solution and the test solution, injecting super The detection is carried out in a high performance liquid chromatograph, and the components to be tested include chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin;
其中,中药组合物的原料组成为:连翘200~300重量份、金银花200~300重量份、炙 麻黄50~100重量份、炒苦杏仁50~100重量份、石膏200~300重量份、板蓝根200~300重量份、绵马贯众200~300重量份、鱼腥草200~300重量份、广藿香50~100重量份、大黄20~70重量份、红景天50~100重量份、薄荷脑5~10重量份、甘草50~100重量份。The raw material composition of the traditional Chinese medicine composition is: 200-300 parts by weight of forsythia, 200-300 parts by weight of honeysuckle, 50-100 parts by weight of ramie, 50-100 parts by weight of fried almond, 200-300 parts by weight of gypsum, Banlangen 200 to 300 parts by weight, 200 to 300 parts by weight of Kumba, 200 to 300 parts by weight of Houttuynia, 50 to 100 parts by weight of patchouli, 20 to 70 parts by weight of rhubarb, 50 to 100 parts by weight of Rhodiola, 5 to 10 parts by weight of menthol and 50 to 100 parts by weight of licorice.
在优选实施方式中,中药组合物的原料组成为:连翘255重量份、金银花255重量份、炙麻黄85重量份、炒苦杏仁85重量份、石膏255重量份、板蓝根255重量份、绵马贯众255重量份、鱼腥草255重量份、广藿香85重量份、大黄51重量份、红景天85重量份、薄荷脑7.5重量份、甘草85重量份。In a preferred embodiment, the raw material composition of the traditional Chinese medicine composition is: 255 parts by weight of forsythia, 255 parts by weight of honeysuckle, 85 parts by weight of ramie, 85 parts by weight of fried almond, 255 parts by weight of gypsum, 255 parts by weight of radix isatimus, 255 parts by weight of Guanzhong, 255 parts by weight of Houttuynia cordata, 85 parts by weight of patchouli, 51 parts by weight of rhubarb, 85 parts by weight of Rhodiola, 7.5 parts by weight of menthol, and 85 parts by weight of licorice.
在一些示例中,将所述中药组合物的原料制成中药组合物后进行检测。所述中药组合物或者中药组合物胶囊剂的制备方法,具体可参考申请号为03143211.5的专利文件中记载的相应内容。In some examples, the raw material of the traditional Chinese medicine composition is tested after being made into a traditional Chinese medicine composition. For the preparation method of the traditional Chinese medicine composition or the Chinese medicine composition capsule, the specific content described in the patent document No. 03143211.5 can be specifically referred to.
在本发明的一些示例中,所述梯度洗脱的程序为:In some examples of the invention, the gradient elution procedure is:
时间/minTime/min A/%A/%
0.000.00 12~1612 to 16
8.008.00 18~2018~20
15.0015.00 22~2522~25
20.0020.00 28~3028~30
25.0025.00 32~3532~35
30.0030.00 38~4338~43
35.0035.00 48~5248~52
40.0040.00 55~6055~60
在一些优选实施方式中,所述梯度洗脱的程序为:In some preferred embodiments, the gradient elution procedure is:
时间/minTime/min A/%A/%
0.000.00 14~1614 to 16
8.008.00 18~2018~20
15.0015.00 23~2523~25
20.0020.00 28~3028~30
25.0025.00 34~3534~35
30.0030.00 40~4340~43
35.0035.00 50~5250~52
40.0040.00 55~6055~60
在一种优选实施方式中,所述梯度洗脱的程序为:In a preferred embodiment, the gradient elution procedure is:
时间/minTime/min A/%A/%
0.000.00 1515
8.008.00 2020
15.0015.00 24twenty four
20.0020.00 3030
25.0025.00 3434
30.0030.00 4040
35.0035.00 5050
40.0040.00 6060
其中,所述磷酸水溶液的浓度为0.1%~1%,例如,0.2%、0.4%、0.6%、0.8%、0.9%;优选为0.1%~0.5%。在优选实施方式中,所述磷酸水溶液的浓度为0.1%。本发明中,如上出现的“A”是指流动相中的甲醇,所述流动相中出现的百分比为体积百分比,“A”的含量百分比是以A+B的总体积为100vol%计。所述磷酸水溶液中浓度的百分比为体积百分比。另外,本发明中出现的甲醇溶液、乙醇溶液的浓度均为体积浓度。The concentration of the aqueous phosphoric acid solution is 0.1% to 1%, for example, 0.2%, 0.4%, 0.6%, 0.8%, 0.9%; preferably 0.1% to 0.5%. In a preferred embodiment, the concentration of the aqueous phosphoric acid solution is 0.1%. In the present invention, "A" as seen above means methanol in the mobile phase, the percentage occurring in the mobile phase is a volume percentage, and the content percentage of "A" is 100 vol% based on the total volume of A + B. The percentage of the concentration in the aqueous phosphoric acid solution is a volume percentage. Further, the concentrations of the methanol solution and the ethanol solution appearing in the present invention are all volume concentrations.
在本发明的一些示例中,步骤a所述有机溶剂选自甲醇、乙醇、丙酮、二氯甲烷和三氯甲烷中的任意一种或几种,优选为60vol%的甲醇水溶液。In some examples of the invention, the organic solvent of step a is selected from any one or more of methanol, ethanol, acetone, dichloromethane, and chloroform, preferably 60 vol% aqueous methanol.
步骤a所述提取的方法包括超声提取或回流提取。在一些示例中,所述供试品溶液在制备时,将中药组合物与步骤a所述有机溶剂混合,通过超声处理和过滤,所得滤液即为供试品溶液。采用超声提取的过程,例如:取中药组合物胶囊剂内容物,采用研钵研磨为细粉,约取0.35g,精密称定,置于25mL容量瓶中,精密加入60%甲醇20mL,密塞、称定重量后,超声处理40分钟(功率250W,频率40kHz);放冷,再称定重量,用60%甲醇补足减失的重量,摇匀,用0.22μm微孔滤膜滤过,取续滤液,即得供试品溶液。采用回流提取的过程,例如:取中药组合物胶囊剂内容物,采用研钵研磨为细粉,约取0.35g,精密称定,置于25mL容量瓶中,精密加入60%甲醇20mL,密塞、称定重量后,加热回流30分钟;放冷,再称定重量,用60%甲醇补足减失的重量,摇匀,用0.22μm微孔滤膜滤过, 取续滤液,即得供试品溶液。The method of extracting in step a includes ultrasonic extraction or reflux extraction. In some examples, the test solution is prepared by mixing the traditional Chinese medicine composition with the organic solvent of step a, by sonication and filtration, and the obtained filtrate is the test solution. The process of ultrasonic extraction is used, for example, taking the capsule content of the traditional Chinese medicine composition, grinding it into a fine powder by a mortar, taking about 0.35 g, accurately weighing, placing it in a 25 mL volumetric flask, precisely adding 60% methanol 20 mL, and sealing After weighing, weighed for 40 minutes (power 250W, frequency 40kHz); let cool, weighed the weight, make up the lost weight with 60% methanol, shake it, filter it with 0.22μm microporous membrane, take The filtrate is continuously supplied, that is, the test solution is obtained. The process of reflux extraction is adopted, for example, taking the capsule content of the traditional Chinese medicine composition, grinding it into a fine powder by a mortar, taking about 0.35 g, accurately weighing, placing it in a 25 mL volumetric flask, precisely adding 60% methanol 20 mL, and sealing After weighing, heat and reflux for 30 minutes; let cool, weigh the weight, make up the lost weight with 60% methanol, shake well, filter with 0.22μm microporous membrane, take the filtrate, then you can test Product solution.
在本发明的一些优选实施方式中,步骤a所述供试品溶液的浓度为10~20mg/mL,例如,12mg/mL、13mg/mL、15mg/mL、17mg/mL、19mg/mL,优选为14mg/mL。In some preferred embodiments of the present invention, the concentration of the test solution in step a is 10-20 mg/mL, for example, 12 mg/mL, 13 mg/mL, 15 mg/mL, 17 mg/mL, 19 mg/mL, preferably. It is 14 mg/mL.
在本发明的一些示例中,步骤b所述有机溶剂选自甲醇、乙醇、丙酮、二氯甲烷和三氯甲烷中的任意一种或几种,优选为甲醇。In some examples of the invention, the organic solvent of step b is selected from any one or more of methanol, ethanol, acetone, dichloromethane, and chloroform, preferably methanol.
在本发明的一些优选实施方式中,步骤b所述对照品溶液中,绿原酸的浓度为55~65μg/mL、咖啡酸的浓度为70~80μg/mL、芦丁的浓度为65~72μg/mL、异绿原酸B的浓度为120~130μg/mL、异绿原酸C的浓度为60~70μg/mL、连翘酯苷A的浓度为75~85μg/mL以及连翘苷的浓度为48~58μg/mL。优选地,所述对照品溶液中绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷的浓度分别为60μg/mL、75μg/mL、68μg/mL、125μg/mL、64μg/mL、80μg/mL和53μg/mL。In some preferred embodiments of the present invention, the reference solution in step b has a concentration of chlorogenic acid of 55-65 μg/mL, a concentration of caffeic acid of 70-80 μg/mL, and a concentration of rutin of 65-72 μg. /mL, the concentration of isochlorogenic acid B is 120-130 μg/mL, the concentration of isochlorogenic acid C is 60-70 μg/mL, the concentration of forsythiaside A is 75-85 μg/mL, and the concentration of forsythin It is 48 to 58 μg/mL. Preferably, the concentration of chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin in the reference solution is 60 μg/mL, 75 μg/ respectively. mL, 68 μg/mL, 125 μg/mL, 64 μg/mL, 80 μg/mL, and 53 μg/mL.
在本发明的一些优选实施方式中,步骤c所述检测的检测波长为200~250nm,例如,220nm、230nm、240nm,优选为210nm;作为检测对象的所述对照品溶液和供试品溶液的进样量为1.0~2.0μL,例如,1.2μL、1.5μL、1.8μL;流速为0.10~0.50mL/min,例如,0.2mL/min、0.3mL/min、0.4mL/min;柱温为20~40℃,例如,30℃、35℃。In some preferred embodiments of the present invention, the detection wavelength detected in the step c is 200 to 250 nm, for example, 220 nm, 230 nm, 240 nm, preferably 210 nm; the reference solution and the test solution as the detection target The injection amount is 1.0 to 2.0 μL, for example, 1.2 μL, 1.5 μL, and 1.8 μL; the flow rate is 0.10 to 0.50 mL/min, for example, 0.2 mL/min, 0.3 mL/min, 0.4 mL/min; and the column temperature is 20 ~40 ° C, for example, 30 ° C, 35 ° C.
实施例1Example 1
中药组合物的组方:连翘255g、金银花255g、炙麻黄85g、炒苦杏仁85g、石膏255g、板蓝根255g、绵马贯众255g、鱼腥草255g、广藿香85g、大黄51g、红景天85g、薄荷脑7.5g、甘草85g。The composition of traditional Chinese medicine composition: Forsythia 255g, Honeysuckle 255g, Castor Yellow 85g, Fried Bitter Almond 85g, Gypsum 255g, Radix Isatidis 255g, Mianma Guanzhong 255g, Houttuynia 255g, Patchouli 85g, Rhubarb 51g, Red View 85g, 7.5g of menthol, 85g of licorice.
将所述中药组合物的原料制成中药组合物胶囊剂进行检测。The raw material of the traditional Chinese medicine composition is made into a capsule of a traditional Chinese medicine composition for detection.
中药组合物胶囊剂的制备方法,包括以下步骤:The preparation method of the traditional Chinese medicine composition capsule comprises the following steps:
(1)将以上中药组合物的十三味中草药原料按重量份进行称取;(1) weighing the thirteen flavor Chinese herbal medicine raw materials of the above traditional Chinese medicine composition by weight;
(2)将作为提取物的广藿香中加6倍质量水蒸馏提取挥发油,提油时间为4小时,收集挥发油,备用;水提取液经过滤后,残渣丢弃,滤液备用;(2) The volatile oil is extracted by adding 6 times of mass water to the extract of patchouli, and the oil extraction time is 4 hours, and the volatile oil is collected and used; after the water extract is filtered, the residue is discarded, and the filtrate is reserved;
(3)将连翘、炙麻黄、鱼腥草、大黄用8倍质量的70vol%乙醇提取二次,第一次提取2小时,第二次提取1.5小时,两次提取所得提取液滤过后,滤液合并,回收乙醇,得到醇 提取液备用;(3) Forsythia, ramie, houttuynia, rhubarb were extracted twice with 8 times the mass of 70 vol% ethanol, the first extraction was 2 hours, the second extraction was 1.5 hours, and the extracts obtained after two extractions were filtered. The filtrates are combined, and the ethanol is recovered to obtain an alcohol extract for use;
(4)将金银花、石膏、板蓝根、绵马贯众、甘草、红景天加9倍质量水煎煮至沸,加入炒苦杏仁,煎煮二次,第一次煎煮1.5小时,第二次煎煮1小时,两次煎煮所得煎液滤过,滤液合并,加入步骤(2)所得广藿香提油后的滤液,浓缩至相对浓度为1.10(60℃)的清膏,加乙醇使含醇量达70vol%,在4℃冷藏24小时,过滤,回收乙醇至无醇味;所得滤液再与步骤(3)所得的备用醇提取液合并,浓缩至相对密度为1.15(60℃)的清膏,喷雾干燥;之后与适量淀粉混匀使其制成颗粒,干燥、过筛,筛出适量细粉;(4) Add honeysuckle, gypsum, Banlangen, Mianma Guanzhong, licorice, Rhodiola and 9 times of quality water to boiling, add fried almonds, cook twice, first time for 1.5 hours, second After decoction for 1 hour, the decoction obtained by two decoctions was filtered, and the filtrate was combined. The filtrate obtained by adding the patch of the patchouli extract obtained in the step (2) was concentrated to a clear concentration of 1.10 (60 ° C), and ethanol was added. The alcohol content was 70 vol%, and the product was refrigerated at 4 ° C for 24 hours, filtered, and the ethanol was recovered to an alcohol-free taste; the obtained filtrate was further combined with the spare alcohol extract obtained in the step (3), and concentrated to a relative density of 1.15 (60 ° C). Clearing paste, spray drying; then mixing with appropriate amount of starch to make granules, drying, sieving, sieving out a suitable amount of fine powder;
(5)将薄荷脑、步骤(2)所得广藿香挥发油用适量乙醇(以能溶解挥发油为限)溶解,喷入步骤(4)所得细粉中,混匀,再与步骤(4)筛出的颗粒混匀,密闭30分钟,装入胶囊,制成1000粒中药组合物胶囊剂,即得。(5) The menthol and the volatile oil of the patchouli obtained in the step (2) are dissolved with an appropriate amount of ethanol (to the extent that the volatile oil can be dissolved), sprayed into the fine powder obtained in the step (4), mixed, and sieved with the step (4). The granules were mixed, sealed for 30 minutes, and filled into capsules to prepare 1000 capsules of the traditional Chinese medicine composition.
<检测方法><Detection method>
步骤a,供试品溶液的制备见2.2的药液配制;Step a, the preparation of the test solution is shown in the preparation of the liquid medicine of 2.2;
步骤b,对照品溶液的制备见2.2的药液配制;Step b, the preparation of the reference solution is shown in the liquid preparation of 2.2;
步骤c,检测:采用超高效液相色谱法,以甲醇(A)-磷酸水溶液(B)为流动相进行梯度洗脱;吸取所述对照品溶液注入超高效液相色谱仪中进行检测,绘制成各对照品溶液的标准曲线;吸取所述供试品溶液,注入超高效液相色谱仪中进行检测,将各成分峰面积带入标准曲线中,测定绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷的含量。Step c, detection: using ultra-high performance liquid chromatography, using methanol (A)-phosphoric acid aqueous solution (B) as a mobile phase for gradient elution; taking the reference solution into an ultra-high performance liquid chromatograph for detection, drawing The standard curve of each reference solution is taken; the test solution is aspirated, injected into an ultra-high performance liquid chromatograph for detection, and the peak area of each component is taken into a standard curve to determine chlorogenic acid, caffeic acid, rutin, The content of isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin.
1实验材料1 experimental material
1.1实验仪器1.1 Experimental equipment
Acquity超高效液相色谱仪(美国Waters公司);Acquity Ultra Performance Liquid Chromatograph (Waters, USA);
万分之一电子分析天平(梅特勒-托利多仪器上海有限公司);One in ten thousand electronic analytical balances (METTLER TOLEDO Instruments Shanghai Co., Ltd.);
超声仪(南京新辰生物科技有限公司);Ultrasound (Nanjing Xinchen Biotechnology Co., Ltd.);
Milli-Q超纯水制备系统(美国Synergy公司);Milli-Q Ultrapure Water Preparation System (Synergy, USA);
微量移液器(德国Eppendorf公司)。Micropipette (Eppendorf, Germany).
1.2药物与试剂1.2 drugs and reagents
中药组合物胶囊40个批次(编号S01-S40),由石家庄以岭药业提供;其原料配方和制备方法如前所述;40 batches of traditional Chinese medicine composition capsules (No. S01-S40), provided by Shijiazhuang Yiling Pharmaceutical; its raw material formula and preparation method are as described above;
将编号S40的中药组合物胶囊剂的内容物分别于高温(60℃)、高湿(RH95%)、光照(4500lx)条件下放置20d得到样品A1、A2、A3(编号S41-S43);The contents of the capsule of the traditional Chinese medicine composition of No. S40 were placed under high temperature (60 ° C), high humidity (RH 95%), and light (4500 lx) conditions for 20 days to obtain samples A1, A2, and A3 (No. S41-S43);
绿原酸(批号151217,供含量测定用时以99.68%计)、咖啡酸(批号151103,供含量测定用时以99.40%计)、异绿原酸B(批号15060708,供含量测定用时以98.82%计)、异绿原酸C(批号151028,供含量测定用时以98.70%计)、连翘苷(批号15102801,供含量测定用时以98.54%计)、连翘酯苷A(批号16082602,供含量测定用时以99.17%计)、芦丁(批号151023,供含量测定用时以98.94%计),由成都普菲德生物科技有限公司提供;Chlorogenic acid (batch No. 151217, 99.68% for content determination), caffeic acid (batch No. 151103 for 99.40% for content determination), isochlorogenic acid B (batch number 15060708, for 98.82% for content determination) ), isochlorogenic acid C (batch 151028, 98.70% for content determination), forsythin (batch 15102801, 98.54% for content determination), forsythiaside A (lot 16082602, for content determination) Used in 99.17%), rutin (lot number 151023, 98.94% for content determination), provided by Chengdu Pfeide Biotechnology Co., Ltd.;
色谱级甲醇、乙腈,色谱级磷酸(85%w/w)均购于美国Thermo公司。Chromatographic grade methanol, acetonitrile, chromatographic grade phosphoric acid (85% w/w) were purchased from Thermo Company, USA.
2实验方法2 experimental methods
2.1色谱条件2.1 chromatographic conditions
①色谱柱为Waters Acquity HSS T3柱(2.1×100mm,1.7μm),流动相为甲醇(A)和0.1%(v/v)磷酸水溶液(B)的混合物,梯度洗脱程序为:1 The column was a Waters Acquity HSS T3 column (2.1 × 100 mm, 1.7 μm), and the mobile phase was a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B). The gradient elution procedure was:
0.00–8.00分钟:5~10%A;8.01–15.00分钟:10~20%A;15.01–20.00分钟:20~25%A;20.01–25.00分钟:25~28%A;25.01–30.00分钟:28~30%A;30.01–35.00分钟:30~45%A;35.01–40.00分钟:45~50%A;检测波长210nm,进样量为3.0μL,流速0.20mL/min,柱温30℃,柱平衡时间为7分钟。0.00–8.00 minutes: 5-10% A; 8.01–15.00 minutes: 10-20% A; 15.01–20.00 minutes: 20-25% A; 20.01–25.00 minutes: 25-28% A; 25.01–30.00 minutes: 28 ~30%A; 30.01–35.00 minutes: 30~45%A; 35.01–40.00 minutes: 45~50%A; detection wavelength 210nm, injection volume 3.0μL, flow rate 0.20mL/min, column temperature 30°C, column The balance time is 7 minutes.
②色谱柱为Waters Acquity HSS T3柱(2.1×100mm,1.7μm),流动相为甲醇(A)和0.1%(v/v)磷酸水溶液(B)的混合物,梯度洗脱程序为:2 The column was a Waters Acquity HSS T3 column (2.1×100 mm, 1.7 μm), and the mobile phase was a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B). The gradient elution procedure was:
0.00–8.00分钟:5~12%A;8.01–15.00分钟:12~22%A;15.01–20.00分钟:22~28%A;20.01–25.00分钟:28~30%A;25.01–30.00分钟:30~48%A;30.01–35.00分钟:48~52%A;35.01–40.00分钟:52~58%A;检测波长210nm,进样量为2.0μL,流速0.20mL/min,柱温30℃,柱平衡时间为7分钟。0.00–8.00 minutes: 5-12% A; 8.01–15.00 minutes: 12-22% A; 15.01–20.00 minutes: 22-28% A; 20.01–25.00 minutes: 28-30% A; 25.01–30.00 minutes: 30 ~48%A; 30.01–35.00 minutes: 48~52%A; 35.01–40.00 minutes: 52~58%A; detection wavelength 210nm, injection volume 2.0μL, flow rate 0.20mL/min, column temperature 30°C, column The balance time is 7 minutes.
③色谱柱为Waters Acquity HSS T3柱(2.1×100mm,1.7μm),流动相为甲醇(A)和0.1%(v/v)磷酸水溶液(B)的混合物,梯度洗脱程序为:3 The column was a Waters Acquity HSS T3 column (2.1×100 mm, 1.7 μm), and the mobile phase was a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B). The gradient elution procedure was:
0.00–8.00分钟:10~20%A;8.01–15.00分钟:20~23%A;15.01–20.00分钟:23~30%A;20.01–25.00分钟:30~33%A;25.01–30.00分钟:33~39%A;30.01–35.00分钟:39~48%A;35.01–40.00分钟:48~60%A;检测波长210nm,进样量为2.0μL,流速0.20mL/min,柱温30℃,柱平衡时间为7分钟。0.00–8.00 minutes: 10-20% A; 8.01–15.00 minutes: 20-23% A; 15.01–20.00 minutes: 23-30% A; 20.01–25.00 minutes: 30–33% A; 25.01–30.00 minutes: 33 ~39%A; 30.01–35.00 minutes: 39~48%A; 35.01–40.00 minutes: 48~60%A; detection wavelength 210nm, injection volume 2.0μL, flow rate 0.20mL/min, column temperature 30°C, column The balance time is 7 minutes.
④色谱柱为Waters Acquity HSS T3柱(2.1×100mm,1.7μm),流动相为甲醇(A)和0.1%(v/v)磷酸水溶液(B)的混合物,梯度洗脱程序为:4 The column was a Waters Acquity HSS T3 column (2.1 x 100 mm, 1.7 μm), and the mobile phase was a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B). The gradient elution procedure was:
0.00–8.00分钟:15~20%A;8.01–15.00分钟:20~24%A;15.01–20.00分钟:24~30%A;20.01–25.00分钟:30~34%A;25.01–30.00分钟:34~40%A;30.01–35.00分钟:40~50%A;35.01–40.00分钟:50~60%A;检测波长210nm,进样量为2.0μL,流速0.20mL/min,柱温30℃,柱平衡时间为7分钟。0.00–8.00 minutes: 15-20% A; 8.01–15.00 minutes: 20-24% A; 15.01–20.00 minutes: 24-30% A; 20.01–25.00 minutes: 30-34% A; 25.01–30.00 minutes: 34 ~40%A; 30.01–35.00 minutes: 40~50%A; 35.01–40.00 minutes: 50~60%A; detection wavelength 210nm, injection volume 2.0μL, flow rate 0.20mL/min, column temperature 30°C, column The balance time is 7 minutes.
2.2药液的配制2.2 Preparation of liquid medicine
对照品溶液制备:精密称取绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷作为对照品取适量,精密称定,置于25mL棕色容量瓶中,加色谱级甲醇制成每1mL含60μg绿原酸、75μg咖啡酸、68μg芦丁、125μg异绿原酸B、64μg异绿原酸C、80μg连翘酯苷A和53μg连翘苷的溶液,即得对照品溶液。Preparation of reference solution: accurately weigh chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin as reference substance, accurately weigh, set In a 25 mL brown volumetric flask, add 6 μg of chlorogenic acid, 75 μg of caffeic acid, 68 μg of rutin, 125 μg of isochlorogenic acid B, 64 μg of isochlorogenic acid C, 80 μg of forsythiaside A and 1 mL of methanol. A solution of 53 μg of forsythin, that is, a reference solution.
供试品溶液制备:取中药组合物胶囊剂的内容物,研钵研为细粉,约取0.35g,精密称定,置于25mL容量瓶中,精密加入60vol%甲醇20mL,密塞,称定重量,超声处理40分钟(功率250W,频率40kHz)进行提取,放冷,再称定重量,用60vol%甲醇补足减失的重量,摇匀,用0.22μm微孔滤膜滤过,取出滤液,即得供试品溶液。Preparation of the test solution: Take the content of the capsule of the traditional Chinese medicine composition, research into a fine powder, about 0.35g, accurately weighed, placed in a 25mL volumetric flask, precision added 60vol% methanol 20mL, densely plug, weigh Determine the weight, sonicate for 40 minutes (power 250W, frequency 40kHz) for extraction, let cool, then weigh the weight, make up the lost weight with 60vol% methanol, shake well, filter with 0.22μm microporous membrane, take out the filtrate , that is, the test solution is available.
3实验结果3 experimental results
3.1色谱条件考察及考察结果3.1 chromatographic conditions and investigation results
精密吸取2.2所得的供试品溶液(编号为S40)2.0μL,注入超高效液相色谱仪,按照色谱条件①、②、③和④进行考察,记录色谱图,见图1-4。Accurately draw 2.0 μL of the test solution (No. S40) obtained from 2.2, inject into an ultra-high performance liquid chromatograph, and observe the chromatographic conditions 1, 2, 3 and 4, and record the chromatogram, see Figure 1-4.
精密吸取2.2所得的对照品混合溶液2.0μL,注入超高效液相色谱仪,按照色谱条件④进行考察,记录色谱图,见图5。Accurately draw 2.0 μL of the control solution obtained from 2.2, inject into an ultra-high performance liquid chromatograph, and observe according to chromatographic conditions 4, and record the chromatogram, see Figure 5.
按照色谱条件①、②、③进行考察时,其中的待测成分不能完全分离,按照色谱条件④进行考察时,其中的7个被测成分(绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、 连翘酯苷A和连翘苷)的分离度、理论塔板数、拖尾因子均满足含量测定要求。According to the chromatographic conditions 1, 2, and 3, the components to be tested cannot be completely separated. According to the chromatographic conditions 4, 7 of the tested components (chlorogenic acid, caffeic acid, rutin, and isochlorogenic) The resolution of the acid B, isochlorogenic acid C, forsythiaside A and forsythin, the number of theoretical plates and the tailing factor all meet the requirements for content determination.
3.2检测方法考察和检测结果3.2 Detection methods and test results
精密度考察:取同一对照品混合溶液作为标准品溶液进行测定,连续进样6次,按色谱条件④进行检测,记录色谱峰面积。结果显示,绿原酸、咖啡酸、连翘酯苷A、异绿原酸B、芦丁、异绿原酸C和连翘苷等7个被测成分的峰面积的RSD均小于5.0%,表明仪器的精密度良好。Accuracy investigation: The same reference mixture solution was used as a standard solution for measurement, and the sample was continuously injected for 6 times, and the chromatographic condition was measured according to the chromatographic condition 4, and the chromatographic peak area was recorded. The results showed that the RSD of the peak areas of seven tested components such as chlorogenic acid, caffeic acid, forsythiaside A, isochlorogenic acid B, rutin, isochlorogenic acid C and forsythin were less than 5.0%. It shows that the precision of the instrument is good.
线性关系考察:精密吸取上述混合对照品溶液0.4μL、0.6μL、0.8μL、1.0μL、1.5μL、2.0μL、3.0μL注入超高效液相色谱仪,按色谱条件④进行检测,记录色谱峰面积。以峰面积为纵坐标(Y),进样量(μg)为横坐标(X),绘制标准曲线。结果相关性系数均大于0.999,表明绿原酸在0.024~0.1788μg、咖啡酸在0.0302~0.2268μg、连翘酯苷A在0.0317~0.2376μg、异绿原酸B在0.0504~0.378μg、芦丁在0.027~0.2028μg、异绿原酸C在0.0252~0.1896μg、连翘苷在0.021~0.1596μg范围内的线性关系较好。Linear relationship investigation: Precision extraction of the above mixed reference solution 0.4μL, 0.6μL, 0.8μL, 1.0μL, 1.5μL, 2.0μL, 3.0μL into the ultra-high performance liquid chromatograph, according to chromatographic conditions 4, record the chromatographic peak area . The standard curve is drawn by taking the peak area as the ordinate (Y) and the injection amount (μg) as the abscissa (X). Results The correlation coefficient was greater than 0.999, indicating that chlorogenic acid was 0.024~0.1788μg, caffeic acid was 0.0302~0.2268μg, forsythiaside A was 0.0317~0.2376μg, isochlorogenic acid B was 0.0504~0.378μg, rutin. The linear relationship is in the range of 0.027 to 0.2028 g, isochlorogenic acid C at 0.0252 to 0.1896 μg, and forsythin in the range of 0.021 to 0.1596 μg.
稳定性考察:取同一供试品溶液(编号为S40),分别于制备后0h、3h、6h、12h、24h内进样,按色谱条件④进行检测,记录各自色谱峰的峰面积,计算对照品溶液中7个被测成分的色谱峰面积的RSD。结果显示,7个被测试物在24h内色谱峰面积的RSD分别为2.45%、3.08%、3.17%、1.89%、3.44%、4.02%和3.78%,表明在24小时内供试品溶液的稳定性良好。Stability investigation: Take the same test solution (No. S40), inject them within 0h, 3h, 6h, 12h, 24h after preparation, and test according to chromatographic conditions 4, record the peak area of each chromatographic peak, calculate the control The RSD of the peak area of the seven tested components in the solution. The results showed that the RSD of the peak area of the four tested materials in 2.4h was 2.45%, 3.08%, 3.17%, 1.89%, 3.44%, 4.02% and 3.78%, respectively, indicating that the test solution was stable within 24 hours. Good sex.
重复性考察:取同一批次(编号为S40)的中药组合物胶囊剂内容物0.35g,共6份,精密称定,按2.2方法制备供试品溶液,按色谱条件④进行测定并计算含量。结果6份供试品中7个被测试物质的含量平均值为绿原酸2.93mg/g、咖啡酸1.41mg/g、连翘酯苷A 2.17mg/g、异绿原酸B 6.66mg/g、芦丁1.08mg/g、异绿原酸C 1.31mg/g连翘苷2.37mg/g;表明方法的重复性良好。Repeatability investigation: Take the same batch (numbered S40) of the content of the capsule of traditional Chinese medicine composition 0.35g, a total of 6 parts, accurately weighed, prepare the test solution according to 2.2 method, determine according to chromatographic condition 4 and calculate the content . Results The average content of 7 tested substances in 6 samples was 2.93 mg/g chlorogenic acid, 1.41 mg/g caffeic acid, 2.17 mg/g of forsythiaside A, and 6.66 mg of isochlorogenic acid. g, rutin 1.08 mg / g, isochlorogenic acid C 1.31 mg / g forsythin 2.37 mg / g; indicating good repeatability of the method.
准确性考察:取同一批次已知待测成分含量的中药组合物胶囊剂(编号S40)内容物0.16~0.18g,置于25mL棕色容量瓶中,分别加入计算的相同含量的标准品物质,按2.2方法制备供试品溶液,按色谱条件④进行检测,并计算回收率。结果表明除了咖啡酸(90.79%)和芦丁(88.91%)的回收率较差外,其余5个被测试物的回收率较好,表明方法的准确性较好。Accuracy investigation: take the same batch of known Chinese medicine composition capsules (No. S40) content 0.16 ~ 0.18g, placed in a 25mL brown volumetric flask, respectively added to calculate the same amount of standard substance, The test solution was prepared according to the method of 2.2, and the detection was carried out according to the chromatographic condition 4, and the recovery rate was calculated. The results showed that except for the recovery rate of caffeic acid (90.79%) and rutin (88.91%), the recovery rate of the other five tested materials was better, indicating that the method was more accurate.
3.3中药组合物胶囊剂中7个活性的被测成分的含量测定:3.3 Determination of the content of 7 active components in the capsule of traditional Chinese medicine composition:
取不同批次的中药组合物胶囊剂,按2.2方法制备供试品溶液,按色谱条件④进行检测,并计算含量,结果见表2。Take different batches of traditional Chinese medicine composition capsules, prepare the test solution according to 2.2 method, test according to chromatographic condition 4, and calculate the content. The results are shown in Table 2.
表2 中药组合物胶囊剂中7个活性的被测成分的含量测定结果Table 2 Results of determination of the content of 7 active components in the capsule of traditional Chinese medicine composition
Figure PCTCN2018110123-appb-000003
Figure PCTCN2018110123-appb-000003
Figure PCTCN2018110123-appb-000004
Figure PCTCN2018110123-appb-000004
《中国药典》规定中药组合物胶囊剂含量测定合格标准为:含连翘苷不得少于0.17mg/粒,以装量0.35g/粒计算,该品不得少于0.49mg/g。表2中的测定结果表明,40个不同批次中药组合物胶囊(编号S01-S40)全部合格;而破坏性样品A1、A2、A3(编号S41-S43)中虽然连翘苷的含量也均合格,但各成分含量的变异较大,绿原酸、咖啡酸、连翘酯苷A、异绿原酸B、芦丁、异绿原酸C、连翘苷含量的变异系数为26%、16%、30%、27%、35%、36%、28%。由此可见,仅以连翘苷一种成分作为质量评价指标是远远不够的,通过本发明的检测方法,可以实现定量测定制剂中的主要代表性化学成分,并且通过多组分化学快速分析来评价制剂的质量。The Chinese Pharmacopoeia stipulates that the qualified standard for the determination of capsules of traditional Chinese medicine composition is: containing at least 0.17 mg/granule of forsythin, and not less than 0.49 mg/g by the amount of 0.35 g/granule. The results of the measurements in Table 2 indicate that 40 different batches of traditional Chinese medicine composition capsules (No. S01-S40) are all qualified; while the destructive samples A1, A2, A3 (No. S41-S43) have the content of forsythin. Qualified, but the variation of the content of each component is large, the variation coefficient of chlorogenic acid, caffeic acid, forsythiaside A, isochlorogenic acid B, rutin, isochlorogenic acid C, forsythin content is 26%, 16%, 30%, 27%, 35%, 36%, 28%. It can be seen that it is not enough to use only one component of forsythin as a quality evaluation index. By the detection method of the invention, the main representative chemical components in the preparation can be quantitatively determined, and the rapid analysis by multi-component chemistry is realized. To evaluate the quality of the formulation.
实施例2Example 2
中药组合物的质量化学评价与生物评价相关性分析:本发明利用PCR技术对小鼠肺组织中IL-6和COX-2进行了测定,发现本发明的中药组合物胶囊剂能显著降低病毒性肺炎模型小鼠肺组织中的IL-6和COX-2的表达,并呈现剂量依赖关系,因此,将IL-6和COX-2作为本发明中药组合物胶囊剂质量生物评价的指标。Correlation analysis between quality chemical evaluation and biological evaluation of traditional Chinese medicine composition: The present invention utilizes PCR technology to measure IL-6 and COX-2 in mouse lung tissue, and finds that the traditional Chinese medicine composition capsule of the present invention can significantly reduce virality The expression of IL-6 and COX-2 in the lung tissue of pneumonia model mice was dose-dependent, and therefore, IL-6 and COX-2 were used as indicators for the biomass evaluation of the capsule quality of the traditional Chinese medicine composition of the present invention.
以中药组合物中7种化学成分(绿原酸、芦丁、连翘酯苷A、连翘酯苷、异绿原酸C、异绿原酸B、咖啡酸)含量指标为自变量,生物效价为应变量,对编号为S01-S40这40批次的中药组合物为统计分析样品,考察抑制COX-2生物效价、抑制巨噬细胞分泌IL-6生物效价与7种化学成分含量测定结果的相关性分析,采用多元统计SPSS统计软件计算。结果见表3。The content of seven chemical components (chlorogenic acid, rutin, forsythiaside A, forsythiaside, isochlorogenic acid C, isochlorogenic acid B, caffeic acid) in the traditional Chinese medicine composition is an independent variable. The potency is the dependent variable. For the 40 batches of the traditional Chinese medicine composition numbered S01-S40, the statistical analysis samples were taken to investigate the inhibition of COX-2 biopotency, inhibition of macrophage secretion of IL-6 biopotency and 7 chemical components. Correlation analysis of the results of the content determination was performed using multivariate statistical SPSS statistical software. The results are shown in Table 3.
表3 生物活性与化学成分含量的相关性分析Table 3 Correlation analysis between biological activity and chemical content
Figure PCTCN2018110123-appb-000005
Figure PCTCN2018110123-appb-000005
Figure PCTCN2018110123-appb-000006
Figure PCTCN2018110123-appb-000006
表3中,r表示相关性,p是统计学指标。In Table 3, r represents correlation and p is a statistical indicator.
从抑制COX-2活性的抗炎生物效价来看,存在相关性的成分为绿原酸、异绿原酸B、异绿原酸C等酸类成分,且为正相关(p<0.05),提示这3种成分的含量越高,其抑制COX-2酶活力的水平也有增高的趋势。因此,在本发明检测方法可实现7种成分的含量和质量检测的情况下,进一步对中药组合物胶囊的化学成分指控时增加这类关联活性的指标成分的检测,在一定程度上提高了中药组合物质量的一致性的评控能力。从抑制巨噬细胞分泌IL-6活性的抗炎生物效价来看,存在相关性的成分为连翘苷,且为正相关(p<0.05),提示连翘苷成分的含量越高,其抑制细胞分泌IL-6的水平也有增高的趋势。提示连翘苷是发挥抗炎作用的有效成分,其含量对中药组合物质量具有一定的影响。From the perspective of anti-inflammatory biopotency against COX-2 activity, the related components were chlorogenic acid, isochlorogenic acid B, isochlorogenic acid C and other acid components, and were positively correlated (p<0.05). It is suggested that the higher the content of these three components, the higher the level of inhibition of COX-2 enzyme activity. Therefore, in the case where the detection method of the present invention can realize the content and quality detection of the seven components, the detection of the index component which increases the correlation activity of the chemical composition of the capsule of the traditional Chinese medicine composition further improves the traditional Chinese medicine to a certain extent. The ability to assess the consistency of composition quality. From the anti-inflammatory biopotency of inhibiting the secretion of IL-6 by macrophages, the related component was forsythin, and it was positively correlated (p<0.05), suggesting that the higher the content of forsythin, the higher its The level of inhibition of IL-6 secretion by cells also tends to increase. It is suggested that forsythin is an effective component for exerting anti-inflammatory effects, and its content has a certain influence on the quality of traditional Chinese medicine compositions.
本发明检测方法相对于《药典》的方法增加了与生物活性相关性强的绿原酸、异绿原酸B、异绿原酸C的成分指标,建立了对中药组合物中7种成分的检测方法,能更全面的表征中药组合物的质量。Compared with the method of "Pharmacopoeia", the detection method of the invention increases the component indexes of chlorogenic acid, isochlorogenic acid B and isochlorogenic acid C which are highly correlated with biological activity, and establishes 7 components in the traditional Chinese medicine composition. The detection method can more fully characterize the quality of the traditional Chinese medicine composition.
实施例3Example 3
中药组合物的组方、中药组合物胶囊剂的制备方法以及检测方法同实施例1;不同之处在于,按色谱条件⑤检测:色谱柱为Waters Acquity HSS T3柱(2.1×100mm,1.7μm),流动相为甲醇(A)和0.1%(v/v)磷酸水溶液(B)的混合物,梯度洗脱的程序为:The preparation method and detection method of the composition of the traditional Chinese medicine composition and the capsule of the traditional Chinese medicine composition are the same as those in the first embodiment; the detection is performed according to the chromatographic condition 5: the column is a Waters Acquity HSS T3 column (2.1×100 mm, 1.7 μm). The mobile phase is a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B). The gradient elution procedure is:
0.00–8.00分钟:12~20%A;8.01–15.00分钟:20~22%A;15.01–20.00分钟:22~28%A;20.01–25.00分钟:28~35%A;25.01–30.00分钟:35~43%A;30.01–35.00分钟:43~50%A;35.01–40.00分钟:50~60%A;检测波长210nm,进样量为2.0μL,流速0.20mL/min,柱温30℃,柱平衡时间为7分钟。0.00–8.00 minutes: 12-20% A; 8.01–15.00 minutes: 20-22% A; 15.01–20.00 minutes: 22-28% A; 20.01–25.00 minutes: 28-35% A; 25.01–30.00 minutes: 35 ~43%A; 30.01–35.00 minutes: 43~50%A; 35.01–40.00 minutes: 50~60%A; detection wavelength 210nm, injection volume 2.0μL, flow rate 0.20mL/min, column temperature 30°C, column The balance time is 7 minutes.
对照品溶液的制备:精密称取绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷对照品适量,精密称定,置于25mL棕色容量瓶中,加色谱级甲醇制成每1mL含60μg、75μg、68μg、125μg、64μg、80μg、53μg的溶液,即得对照品溶液。Preparation of reference solution: accurately weigh chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin reference substance, accurately weighed, placed In a 25 mL brown volumetric flask, a solution containing 60 μg, 75 μg, 68 μg, 125 μg, 64 μg, 80 μg, and 53 μg per 1 mL was added to obtain a reference solution.
供试品溶液的制备:取中药组合物胶囊剂(编号S40)内容物,研钵研为细粉,约取0.35g,精密称定,置于25mL容量瓶中,精密加入60%甲醇20mL,密塞,称定重量,超声处理40分钟(功率250W,频率40kHz),放冷,再称定重量,用60%甲醇补足减失的重量,摇匀,用0.22μm微孔滤膜滤过,取续滤液,即得供试品溶液。Preparation of the test solution: Take the content of the traditional Chinese medicine composition capsule (No. S40), research into a fine powder, about 0.35g, accurately weighed, placed in a 25mL volumetric flask, precisely added 60% methanol 20mL, Concealed, weighed, sonicated for 40 minutes (power 250W, frequency 40kHz), let cool, then weighed, with 60% methanol to make up the lost weight, shake, filtered through a 0.22μm microporous membrane, The filtrate is taken to obtain the test solution.
测定:精密吸取供试品溶液(编号S40)和混合对照品混合溶液各2.0μL,注入超高效液相色谱仪,记录色谱图;供试品溶液和对照品溶液的谱图见图6和图7。Determination: Precision extraction of the test solution (No. S40) and mixed control solution mixed solution of 2.0μL, injected into the ultra-high performance liquid chromatograph, record the chromatogram; the spectrum of the test solution and the reference solution are shown in Figure 6 and 7.
实施例4Example 4
中药组合物的组方、中药组合物胶囊剂的制备方法以及检测方法同实施例1;不同之处在于,按色谱条件⑥检测:色谱柱为Waters Acquity HSS T3柱(2.1×100mm,1.7μm),流动相为甲醇(A)和0.1%(v/v)磷酸水溶液(B)的混合物,梯度洗脱的程序为:The preparation method and detection method of the prescription of the traditional Chinese medicine composition and the capsule of the traditional Chinese medicine composition are the same as those in the first embodiment; the detection is performed according to the chromatographic condition 6: the column is a Waters Acquity HSS T3 column (2.1×100 mm, 1.7 μm). The mobile phase is a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B). The gradient elution procedure is:
0.00–8.00分钟:16~18%A;8.01–15.00分钟:18~25%A;15.01–20.00分钟:25~28%A;20.01–25.00分钟:28~32%A;25.01–30.00分钟:32~42%A;30.01–35.00分钟:42~48%A;35.01–40.00分钟:48~58%A;检测波长210nm,进样量为2.0μL,流速0.20mL/min,柱温30℃,柱平衡时间为7分钟。0.00–8.00 minutes: 16-18% A; 8.01–15.00 minutes: 18 to 25% A; 15.01–20.00 minutes: 25 to 28% A; 20.01–25.00 minutes: 28 to 32% A; 25.01–30.00 minutes: 32 ~42%A; 30.01–35.00 minutes: 42~48%A; 35.01–40.00 minutes: 48~58%A; detection wavelength 210nm, injection volume 2.0μL, flow rate 0.20mL/min, column temperature 30°C, column The balance time is 7 minutes.
对照品溶液的制备:精密称取绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷对照品适量,精密称定,置于25mL棕色容量瓶中,加色谱级甲醇制成每1mL含60μg、75μg、68μg、125μg、64μg、80μg、53μg的溶液,即得对照品溶液。Preparation of reference solution: accurately weigh chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin reference substance, accurately weighed, placed In a 25 mL brown volumetric flask, a solution containing 60 μg, 75 μg, 68 μg, 125 μg, 64 μg, 80 μg, and 53 μg per 1 mL was added to obtain a reference solution.
供试品溶液的制备:取中药组合物胶囊剂内容物(编号S40),研钵研为细粉,约取0.35g,精密称定,置于25mL容量瓶中,精密加入60%甲醇20mL,密塞,称定重量,超声处理40分钟(功率250W,频率40kHz),放冷,再称定重量,用60%甲醇补足减失的重量,摇匀,用0.22μm微孔滤膜滤过,取续滤液,即得供试品溶液。Preparation of the test solution: Take the content of the capsule of the traditional Chinese medicine composition (No. S40), research into a fine powder, take about 0.35g, accurately weigh it, place it in a 25mL volumetric flask, and accurately add 60mL methanol to 20mL. Concealed, weighed, sonicated for 40 minutes (power 250W, frequency 40kHz), let cool, then weighed, with 60% methanol to make up the lost weight, shake, filtered through a 0.22μm microporous membrane, The filtrate is taken to obtain the test solution.
测定:精密吸取供试品溶液(编号S40)和混合对照品混合溶液各2.0μL,注入超高效液相色谱仪,记录色谱图;供试品溶液和对照品溶液的谱图见图8和图9。Determination: Precision extraction of the test solution (No. S40) and mixed control solution mixed solution of 2.0μL, injected into the ultra-high performance liquid chromatograph, record the chromatogram; the spectrum of the test solution and the reference solution are shown in Figure 8 and 9.
实施例5Example 5
中药组合物的组方、中药组合物胶囊剂的制备方法以及检测方法同实施例1;不同之处在于,按色谱条件⑦检测:色谱柱为Waters Acquity HSS T3柱(2.1×100mm,1.7μm), 流动相为甲醇(A)和0.1%(v/v)磷酸水溶液(B)的混合物,梯度洗脱的程序为:The preparation method and the detection method of the prescription of the traditional Chinese medicine composition and the capsule of the traditional Chinese medicine composition are the same as those in the first embodiment; the difference is that the chromatography column is the waters Acquity HSS T3 column (2.1×100 mm, 1.7 μm). The mobile phase is a mixture of methanol (A) and 0.1% (v/v) aqueous phosphoric acid (B). The gradient elution procedure is:
0.00–8.00分钟:14~20%A;8.01–15.00分钟:20~25%A;15.01–20.00分钟:25~30%A;20.01–25.00分钟:30~35%A;25.01–30.00分钟:35~42%A;30.01–35.00分钟:42~51%A;35.01–40.00分钟:51~60%A;检测波长210nm,进样量为2.0μL,流速0.20mL/min,柱温30℃,柱平衡时间为7分钟。0.00–8.00 minutes: 14-20% A; 8.01–15.00 minutes: 20-25% A; 15.01–20.00 minutes: 25-30% A; 20.01–25.00 minutes: 30-35% A; 25.01–30.00 minutes: 35 ~42%A; 30.01–35.00 minutes: 42~51%A; 35.01–40.00 minutes: 51~60%A; detection wavelength 210nm, injection volume 2.0μL, flow rate 0.20mL/min, column temperature 30°C, column The balance time is 7 minutes.
对照品溶液的制备:精密称取绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷对照品适量,精密称定,置于25mL棕色容量瓶中,加色谱级甲醇制成每1mL含60μg、75μg、68μg、125μg、64μg、80μg、53μg的溶液,即得对照品溶液。Preparation of reference solution: accurately weigh chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin reference substance, accurately weighed, placed In a 25 mL brown volumetric flask, a solution containing 60 μg, 75 μg, 68 μg, 125 μg, 64 μg, 80 μg, and 53 μg per 1 mL was added to obtain a reference solution.
供试品溶液的制备:取中药组合物胶囊剂内容物(编号S40),研钵研为细粉,约取0.35g,精密称定,置于25mL容量瓶中,精密加入60%甲醇20mL,密塞,称定重量,超声处理40分钟(功率250W,频率40kHz),放冷,再称定重量,用60%甲醇补足减失的重量,摇匀,用0.22μm微孔滤膜滤过,取续滤液,即得供试品溶液。Preparation of the test solution: Take the content of the capsule of the traditional Chinese medicine composition (No. S40), research into a fine powder, take about 0.35g, accurately weigh it, place it in a 25mL volumetric flask, and accurately add 60mL methanol to 20mL. Concealed, weighed, sonicated for 40 minutes (power 250W, frequency 40kHz), let cool, then weighed, with 60% methanol to make up the lost weight, shake, filtered through a 0.22μm microporous membrane, The filtrate is taken to obtain the test solution.
测定:精密吸取供试品溶液(编号S40)和混合对照品混合溶液各2.0μL,注入超高效液相色谱仪,记录色谱图;供试品溶液和对照品溶液的谱图见图10和图11。Determination: Precision extraction of the test solution (No. S40) and mixed control solution mixed solution of 2.0μL, injected into the ultra-high performance liquid chromatograph, record the chromatogram; the spectrum of the test solution and the reference solution are shown in Figure 10 and 11.
结果表明,按照色谱条件①、②、③进行考察时,其中的待测成分不能完全分离,实施例1中按照色谱条件④进行考察时,其中的7个被测成分(绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷)的分离度、理论塔板数、拖尾因子均满足含量测定要求,系统适用性良好。实施例3-5按照色谱条件⑤-⑦进行考察,检测结果中7种成分的分离度、理论塔板数、拖尾因子均满足含量测定要求。The results showed that the components to be tested could not be completely separated according to the chromatographic conditions 1, 2, and 3. In the case of examining the chromatographic conditions in Example 1, seven of the components to be tested (chlorogenic acid, caffeic acid) The separation degree, theoretical plate number and tailing factor of rutin, chlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin all meet the requirements for content determination, and the system has good applicability. Example 3-5 was examined according to the chromatographic conditions 5-7. The separation degree, the number of theoretical plates, and the tailing factor of the seven components in the test results all met the requirements for content determination.
以上已经描述了本发明的各实施例,上述说明是示例性的,并非穷尽性的,并且也不限于所披露的各实施例。在不偏离所说明的各实施例的范围和精神的情况下,对于本技术领域的普通技术人员来说许多修改和变更都是显而易见的。The embodiments of the present invention have been described above, and the foregoing description is illustrative, not limiting, and not limited to the disclosed embodiments. Numerous modifications and changes will be apparent to those skilled in the art without departing from the scope of the invention.

Claims (13)

  1. 一种中药组合物的检测方法,其特征在于,所述检测方法包括如下步骤:A method for detecting a traditional Chinese medicine composition, characterized in that the detection method comprises the following steps:
    步骤a,供试品溶液的制备:取中药组合物,例如中药组合物胶囊剂内容物,加入有机溶剂提取,即得供试品溶液;Step a, preparing a test solution: taking a Chinese medicine composition, for example, a capsule content of a traditional Chinese medicine composition, and extracting by adding an organic solvent, thereby obtaining a test solution;
    步骤b,对照品溶液的制备:取绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷,加入有机溶剂溶解,即得对照品溶液;Step b, preparation of the reference solution: taking chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin, dissolved in an organic solvent, that is, a control Product solution
    步骤c,检测:采用超高效液相色谱法,以甲醇(A)-磷酸水溶液(B)为流动相梯度洗脱;Step c, detection: using ultra performance liquid chromatography, using methanol (A)-phosphoric acid aqueous solution (B) as a mobile phase gradient elution;
    其中,中药组合物的原料组成为:连翘200~300重量份、金银花200~300重量份、炙麻黄50~100重量份、炒苦杏仁50~100重量份、石膏200~300重量份、板蓝根200~300重量份、绵马贯众200~300重量份、鱼腥草200~300重量份、广藿香50~100重量份、大黄20~70重量份、红景天50~100重量份、薄荷脑5~10重量份、甘草50~100重量份。The raw material composition of the traditional Chinese medicine composition is: 200-300 parts by weight of forsythia, 200-300 parts by weight of honeysuckle, 50-100 parts by weight of ramie, 50-100 parts by weight of fried almond, 200-300 parts by weight of gypsum, Banlangen 200 to 300 parts by weight, 200 to 300 parts by weight of Kumba, 200 to 300 parts by weight of Houttuynia, 50 to 100 parts by weight of patchouli, 20 to 70 parts by weight of rhubarb, 50 to 100 parts by weight of Rhodiola, 5 to 10 parts by weight of menthol and 50 to 100 parts by weight of licorice.
  2. 如权利要求1所述的检测方法,其特征在于,所述中药组合物的原料组成为:连翘255重量份、金银花255重量份、炙麻黄85重量份、炒苦杏仁85重量份、石膏255重量份、板蓝根255重量份、绵马贯众255重量份、鱼腥草255重量份、广藿香85重量份、大黄51重量份、红景天85重量份、薄荷脑7.5重量份、甘草85重量份。The detecting method according to claim 1, wherein the raw material composition of the traditional Chinese medicine composition is: 255 parts by weight of forsythia, 255 parts by weight of honeysuckle, 85 parts by weight of ramie, 85 parts by weight of fried almond, gypsum 255. Parts by weight, 255 parts by weight of Radix, 255 parts by weight of hunters, 255 parts by weight of Houttuynia, 85 parts by weight of patchouli, 51 parts by weight of rhubarb, 85 parts by weight of Rhodiola, 7.5 parts by weight of menthol, licorice 85 Parts by weight.
  3. 如权利要求1或2所述的检测方法,其特征在于,步骤c的检测过程中,采用超高效液相色谱法,以甲醇(A)-磷酸水溶液(B)为流动相梯度洗脱;分别吸取所述对照品溶液和供试品溶液,注入超高效液相色谱仪中进行检测,测定绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷的含量。The detecting method according to claim 1 or 2, wherein in the detecting process of the step c, ultra-high performance liquid chromatography is employed, and the methanol (A)-phosphoric acid aqueous solution (B) is used as a mobile phase gradient elution; The reference solution and the test solution are aspirated and injected into an ultra-high performance liquid chromatograph for determination of chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside A and forsythin content.
  4. 如权利要求1-3任一项所述的检测方法,其特征在于,所述梯度洗脱的程序为:The detecting method according to any one of claims 1 to 3, wherein the gradient elution procedure is:
    时间/minTime/min A/%A/% 0.000.00 12~1612 to 16 8.008.00 18~2018~20 15.0015.00 22~2522~25 20.0020.00 28~3028~30 25.0025.00 32~3532~35
    30.00 38~43 35.00 48~52 40.00 55~60
    30.00 38~43 35.00 48~52 40.00 55~60
    .
  5. 如权利要求4所述的检测方法,其特征在于,所述梯度洗脱的程序为:The detecting method according to claim 4, wherein the gradient elution program is:
    时间/min A/% 0.00 15 8.00 20 15.00 24 20.00 30 25.00 34 30.00 40 35.00 50 40.00 60
    Time/min A/% 0.00 15 8.00 20 15.00 twenty four 20.00 30 25.00 34 30.00 40 35.00 50 40.00 60
    .
  6. 如权利要求4所述的检测方法,其特征在于,所述磷酸水溶液的浓度为0.1%~1%;优选为0.1%~0.5%。The detecting method according to claim 4, wherein the concentration of the aqueous phosphoric acid solution is from 0.1% to 1%; preferably from 0.1% to 0.5%.
  7. 如权利要求1或2所述的检测方法,其特征在于,步骤a所述有机溶剂选自甲醇、乙醇、丙酮、二氯甲烷和三氯甲烷中的任意一种或几种,优选为60%的甲醇溶液。The detecting method according to claim 1 or 2, wherein the organic solvent in the step a is selected from any one or more of methanol, ethanol, acetone, dichloromethane and chloroform, preferably 60%. Methanol solution.
  8. 如权利要求1或2或7所述的检测方法,其特征在于,步骤a所述提取的方法包括超声提取或回流提取;优选地,所述供试品溶液的制备中,将中药组合物与步骤a所述有机溶剂混合,通过超声处理或回流提取,之后过滤,所得滤液即为供试品溶液。The detecting method according to claim 1 or 2 or 7, wherein the method of extracting in step a comprises ultrasonic extraction or reflux extraction; preferably, in the preparation of the test solution, the traditional Chinese medicine composition is The organic solvent in step a is mixed, extracted by sonication or reflux, and then filtered, and the obtained filtrate is the test solution.
  9. 根据权利要求1或2或8所述的检测方法,其特征在于,步骤a供试品溶液的浓度为10~20mg/mL,更优选为14mg/mL。The detection method according to claim 1 or 2 or 8, wherein the concentration of the test solution in step a is 10 to 20 mg/mL, more preferably 14 mg/mL.
  10. 如权利要求1或2所述的检测方法,其特征在于,步骤b所述有机溶剂选自甲醇、乙醇、丙酮、二氯甲烷和三氯甲烷中的任意一种或几种,优选为甲醇。The detecting method according to claim 1 or 2, wherein the organic solvent in the step b is selected from any one or more selected from the group consisting of methanol, ethanol, acetone, dichloromethane and chloroform, preferably methanol.
  11. 如权利要求1或2所述的检测方法,其特征在于,步骤b所述对照品溶液中绿原酸、咖啡酸、芦丁、异绿原酸B、异绿原酸C、连翘酯苷A和连翘苷的浓度分别为55~65 μg/mL、70~80μg/mL、65~72μg/mL、120~130μg/mL、60~70μg/mL、75~85μg/mL和48~58μg/mL。The detection method according to claim 1 or 2, wherein the reference solution is chlorogenic acid, caffeic acid, rutin, isochlorogenic acid B, isochlorogenic acid C, forsythiaside in the reference solution. The concentrations of A and forsythin are 55-65 μg/mL, 70-80 μg/mL, 65-72 μg/mL, 120-130 μg/mL, 60-70 μg/mL, 75-85 μg/mL, and 48-58 μg/ mL.
  12. 如权利要求1-11中任一项所述的检测方法,其特征在于,所述检测的检测波长为200~250nm,优选为210nm;进样量为1.0~2.0μL;流速为0.10~0.50mL/min;柱温为20~40℃。The detecting method according to any one of claims 1 to 11, wherein the detected detection wavelength is 200 to 250 nm, preferably 210 nm; the injection amount is 1.0 to 2.0 μL; and the flow rate is 0.10 to 0.50 mL. /min; The column temperature is 20 to 40 °C.
  13. 如权利要求1-12中任一项所述的检测方法,其特征在于,将所述中药组合物的原料制成中药组合物进行检测;优选地,所述中药组合物的制备方法包括如下步骤:The detection method according to any one of claims 1 to 12, wherein the raw material of the traditional Chinese medicine composition is made into a traditional Chinese medicine composition for detection; preferably, the preparation method of the traditional Chinese medicine composition comprises the following steps :
    (1)广藿香加水蒸馏提取挥发油,收集挥发油;将水溶液过滤后,得到滤液;(1) extracting volatile oil from patchouli and adding water to collect volatile oil; filtering the aqueous solution to obtain a filtrate;
    (2)将连翘、炙麻黄、鱼腥草、大黄用70vol%乙醇提取,再将提取液过滤后,回收乙醇,得到醇提取液;(2) extracting forsythia, ramie, houttuynia, rhubarb with 70 vol% ethanol, filtering the extract, and recovering the ethanol to obtain an alcohol extract;
    (3)将金银花、石膏、板蓝根、绵马贯众、甘草、红景天加水煎煮至沸,加入炒苦杏仁煎煮,再将煎煮所得煎液过滤得到的滤液中加入步骤(1)广藿香提油、过滤后的滤液,浓缩至相对浓度为1.10~1.15,加乙醇使含醇量达70vol%,在2-4℃冷藏20-24小时,过滤,滤液回收乙醇后与步骤(2)所得的醇提取液合并,浓缩至相对密度为1.10~1.15,喷雾干燥;再与淀粉混匀使其制成颗粒,干燥、过筛,筛出细粉;(3) Add honeysuckle, gypsum, Banlangen, Mianmaguanzhong, licorice, Rhodiola to boil, add frying almonds, and add the filtrate obtained by decoction to the filtrate (1). The patchouli oil and the filtered filtrate are concentrated to a relative concentration of 1.10 to 1.15, ethanol is added to make the alcohol content 70 vol%, refrigerated at 2-4 ° C for 20-24 hours, filtered, and the filtrate is recovered and the step is recovered. 2) The obtained alcohol extracts are combined, concentrated to a relative density of 1.10 to 1.15, spray-dried; then mixed with starch to form granules, dried, sieved, and sieved to a fine powder;
    (4)将薄荷脑、步骤(1)所得广藿香挥发油用乙醇溶解后,喷至步骤(3)所得细粉中并混匀;再与步骤(3)过筛后所得颗粒混匀,优选还包括密闭20-30min的操作;(4) The menthol and the volatile oil of the patchouli obtained in the step (1) are dissolved in ethanol, sprayed into the fine powder obtained in the step (3), and mixed; and the particles obtained after the step (3) are mixed, preferably. Also includes the operation of sealing for 20-30min;
    进一步优选还包括如下操作:将步骤(4)所得制剂装入胶囊,制成中药组合物胶囊剂。Further preferably, the method further comprises the steps of: filling the preparation obtained in the step (4) into a capsule to prepare a capsule of the traditional Chinese medicine composition.
PCT/CN2018/110123 2017-10-13 2018-10-12 Ultra-high-performance liquid chromatography detection method for traditional chinese medicine composition WO2019072247A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710954961.XA CN109668970B (en) 2017-10-13 2017-10-13 Ultra-high performance liquid chromatography detection method for traditional Chinese medicine composition
CN201710954961.X 2017-10-13

Publications (1)

Publication Number Publication Date
WO2019072247A1 true WO2019072247A1 (en) 2019-04-18

Family

ID=66100417

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/110123 WO2019072247A1 (en) 2017-10-13 2018-10-12 Ultra-high-performance liquid chromatography detection method for traditional chinese medicine composition

Country Status (2)

Country Link
CN (1) CN109668970B (en)
WO (1) WO2019072247A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114990054A (en) * 2022-07-22 2022-09-02 成都艾伟孚生物科技有限公司 Formula of sperm-washing and fertilization liquid for assisted reproduction
CN115737570A (en) * 2022-11-18 2023-03-07 南京中医药大学 Method for reducing hygroscopicity of spray-dried particles of traditional Chinese medicine extract

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110716001B (en) * 2019-11-29 2020-07-07 山东汉方制药有限公司 Method for detecting characteristic spectrum of compound phellodendron amurense liquid preparation
CN114184717B (en) * 2021-11-29 2023-12-12 瑞普(天津)生物药业有限公司 Quality detection method of veterinary Shuanghuanglian oral liquid based on spectral efficiency relation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1483463A (en) * 2003-07-01 2004-03-24 河北以岭医药研究院有限公司 Anti-virus Chinese medicine composition and preparation process thereof
CN104345111A (en) * 2013-08-08 2015-02-11 河北以岭医药研究院有限公司 Determination method for content of multiple active compositions in traditional Chinese medicine composition preparation
CN107149623A (en) * 2016-03-03 2017-09-12 石家庄以岭药业股份有限公司 A kind of content assaying method of Chinese medicine composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104101657B (en) * 2013-04-02 2017-04-12 石家庄以岭药业股份有限公司 Method for determining content of multiple components in Chinese medicinal composition preparation
CN103308615B (en) * 2013-05-30 2014-11-12 哈药集团中药二厂 Method for content determination of multiple components in traditional Chinese medicinal preparation Shuanghuanglian for injection
CN106290599B (en) * 2015-06-12 2020-07-21 石家庄以岭药业股份有限公司 Content determination method of traditional Chinese medicine composition
CN107153098B (en) * 2016-03-03 2021-05-04 石家庄以岭药业股份有限公司 Method for measuring fingerprint spectrum of traditional Chinese medicine composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1483463A (en) * 2003-07-01 2004-03-24 河北以岭医药研究院有限公司 Anti-virus Chinese medicine composition and preparation process thereof
CN104345111A (en) * 2013-08-08 2015-02-11 河北以岭医药研究院有限公司 Determination method for content of multiple active compositions in traditional Chinese medicine composition preparation
CN107149623A (en) * 2016-03-03 2017-09-12 石家庄以岭药业股份有限公司 A kind of content assaying method of Chinese medicine composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LI, ET AL: "UPLC Fingerprints of Ultrasound Countercurrent Extraction Solution from Lianhua Qingwen Capsule", CHINA PHARMACEUTICALS, 5 December 2013 (2013-12-05) *
YAN ET AL.: "Application of Ultra-High Performance Liquid Chromatography in the Determination of Traditional Chinese Medicine", ASIA-PACIFIC TRADITIONAL MEDICINE, 30 November 2011 (2011-11-30) *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114990054A (en) * 2022-07-22 2022-09-02 成都艾伟孚生物科技有限公司 Formula of sperm-washing and fertilization liquid for assisted reproduction
CN115737570A (en) * 2022-11-18 2023-03-07 南京中医药大学 Method for reducing hygroscopicity of spray-dried particles of traditional Chinese medicine extract

Also Published As

Publication number Publication date
CN109668970B (en) 2020-11-10
CN109668970A (en) 2019-04-23

Similar Documents

Publication Publication Date Title
WO2019072247A1 (en) Ultra-high-performance liquid chromatography detection method for traditional chinese medicine composition
CN105259295B (en) Quality detection method for ginseng, cassia twig and poria cocos oral solution
CN102590433B (en) A kind of quality determining method of the smooth preparation of liver
CN103954724B (en) Method for detecting Jingfang granules
CN102323371B (en) Detection method of haemostasis medicine
CN105287875B (en) Preparation method and quality control method of four-ingredient decoction formula granules
CN102269751B (en) Detection method of Liuweinengxiao preparation
CN108896673B (en) Method for determining content of chlorogenic acid, luteolin and apigenin in spider fruits
CN104042824B (en) Preparation and detecting methods of traditional Chinese medicine composition for treating wind-cold-wetness evil
CN103245753A (en) Mass detection method for motherwort grains
CN102579734B (en) Traditional Chinese medicine composition of bone healing medicine, preparing method thereof and detecting method thereof
CN102353735B (en) Quality detection method for Tongmai Tangyanming capsule
CN102552616A (en) Detection method for tablets capable of relaxing muscles and stimulating blood circulation
CN102218122A (en) Quality control and detection method for sea dragon and gecko oral liquid
CN101647993B (en) Medicament for treating flu and preparation and detection method thereof
CN102552478A (en) Quality detection method of Nine Ingredient Hemorrhoid Capsules
CN105158352B (en) A kind of method for building up of finger-print of perhexiline piece and its application
CN101607037B (en) Detecting method of lanzhi brain-tranquilizing capsule
CN110988198A (en) Content determination method of bi-tong ning capsules
CN110638990A (en) Extraction process of cassia twig, peony and rhizoma anemarrhenae prescription preparation extract
CN100402059C (en) Quality control method of sinew soothing and pain relieving preparation
CN115575551A (en) Detection method of rhizoma bletillae, preparation method of rhizoma bletillae control extract and application of rhizoma bletillae control extract
CN109270186A (en) A kind of Dan peach kernel formulation characteristics map detection method
CN101766664A (en) Extraction method of total saponin of Radix Ilicis Asprellae and quality detection method thereof
CN108535399A (en) A kind of detection method of Fuyankang pill

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18865718

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18865718

Country of ref document: EP

Kind code of ref document: A1